TW200841093A - Agent for alignment treatment of liquid crystal and liquid crystal display element using the same - Google Patents

Agent for alignment treatment of liquid crystal and liquid crystal display element using the same Download PDF

Info

Publication number
TW200841093A
TW200841093A TW096141006A TW96141006A TW200841093A TW 200841093 A TW200841093 A TW 200841093A TW 096141006 A TW096141006 A TW 096141006A TW 96141006 A TW96141006 A TW 96141006A TW 200841093 A TW200841093 A TW 200841093A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
ring
crystal alignment
treatment agent
carbon atoms
Prior art date
Application number
TW096141006A
Other languages
Chinese (zh)
Other versions
TWI407214B (en
Inventor
Kazuyoshi Hosaka
Kohei Goto
Noritoshi Miki
Kenzo Yada
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Publication of TW200841093A publication Critical patent/TW200841093A/en
Application granted granted Critical
Publication of TWI407214B publication Critical patent/TWI407214B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/04Oxygen-containing compounds
    • C08K5/15Heterocyclic compounds having oxygen in the ring
    • C08K5/151Heterocyclic compounds having oxygen in the ring having one oxygen atom in the ring
    • C08K5/1525Four-membered rings
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Nonlinear Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Mathematical Physics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Liquid Crystal (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

Disclosed is an agent for the alignment treatment of a liquid crystal, which has a highly stabilized pretilt angle. Also disclosed is a liquid crystal display element which has less change in a pretilt angle and also has excellent display reliability. The agent for the alignment treatment of a liquid crystal comprises at least one polymer selected from the group consisting of polyamic acid and polyimide and a crosslinkable compound having at least two oxetane groups represented by the formula [I] in the molecule.

Description

200841093 九、發明說明 【發明所屬之技術領域】 本發明係關於用於製作液晶配向膜之液晶配向處理劑 、及使用其之液晶顯示元件。 【先前技術】 於液晶顯示元件中,液晶配向膜擔任使液晶配向於一 定的方向之作用,現在,被應用於工業上的主要液晶配向 膜,係藉由將由聚醯亞胺前驅物之聚醯胺酸或聚醯亞胺溶 液所成的聚醯亞胺系的液晶配向處理劑,塗佈於基板進行 成膜而製作,相對於基板面使液晶爲平行配向或傾斜配向 時,成膜後,再藉由硏磨(rubbing)來進行表面延伸處理 。此外,亦提出利用藉由偏光紫外線照射等之各向異性光 化學反應取代硏磨處理之方法,近年朝向工業化進行檢討 〇 液晶配向膜,亦被使用於進行控制相對於基板之液晶 的角度,亦即控制液晶的傾斜角,但因爲液晶顯示元件高 性能化,及其利用範圍逐年擴大中,不僅是要能夠得到所 定的傾斜角,傾斜角的安定性亦變得更加重要。 由傾斜角的安定性的觀點而言,在液晶配向膜的製造 步驟中,以不論硏磨條件如何皆要得到一定的傾斜角爲目 的,提案使聚醯亞胺系的液晶配向處理劑中含有分子內具 有2個以上的環氧之化合物(例如參考專利文獻〗)。 此外,在液晶顯示元件的製造步驟中,爲了提高液晶 -5- 200841093 的配向均一性,會有封入液晶後加熱處理而使液晶一度各 向同(isotropy )化的情況,惟,傾斜角的安定性低時, 會引起此各向同化處理後無法得到目標大小的傾斜角,或 傾斜角產生偏差之問題。特別是,爲了得到高亮度而使用 發熱量大的背光之液晶顯示元件、或車載用途所使用的液 晶顯示元件,例如車用導航系統及儀表面板,會有在長時 間局溫環境下使用或放置的情況,在如此的嚴苛條件下, 傾斜角慢慢變化時,會引起無法得到初期的顯示特性,或 顯示上產生不均勻等問題。 【發明內容】 [發明所欲解決之課題] 本發明係鑑於上述情況而完成者,其課題係提供即使 在長時間高溫環境下,傾斜角的安定性仍優異之液晶配向 處理劑,以及提供傾斜角的變化少且顯示的信賴性優異之 液晶顯示元件。 此外,隨著近年來的液晶顯示元件中畫素的高密度化 '基板表面結構的高立體化(表面的凹凸大),液晶顯示 面內的硏磨強度的偏差大於先前技術的結果,會發生硏磨 弱的部份則液晶的配向規制力變弱’且部份的顯示缺陷發 生等問題。所以,提供除了提昇傾斜角的安定性之外,即 使對於弱的硏磨條件,亦即不論硏磨條件如何’液晶的配 向性不降低的液晶配向處理劑,亦爲本發明的課題。 200841093 [用以解決課題之手段] 亦即,本發明爲具有以下要旨之發明。 (1 ) 一種液晶配向處理劑,其係含有下述(A )成份 及(B )成份, (A) 由聚醯胺酸及聚醯亞胺所成的群中所選出的 至少一種的聚合物、 (B) 分子內中具有至少2個下述式[1]所表示的氧 雜環丁烷基之交聯性化合物。 [化1][Technical Field] The present invention relates to a liquid crystal alignment treatment agent for producing a liquid crystal alignment film, and a liquid crystal display element using the same. [Prior Art] In the liquid crystal display element, the liquid crystal alignment film serves to align the liquid crystal in a certain direction. Now, it is applied to the main liquid crystal alignment film in the industry by polycondensation of the polyimide precursor. A polyimine-based liquid crystal alignment treatment agent prepared by a solution of an amino acid or a polyimide reaction is applied to a substrate to form a film, and when the liquid crystal is aligned in a parallel direction or obliquely aligned with respect to the substrate surface, after film formation, The surface extension treatment is performed by rubbing. In addition, it has also been proposed to replace the honing treatment by an anisotropic photochemical reaction such as polarized ultraviolet ray irradiation. In recent years, it has been reviewed for industrialization, and the liquid crystal alignment film is also used to control the angle of the liquid crystal with respect to the substrate. That is, the tilt angle of the liquid crystal is controlled. However, since the liquid crystal display element is improved in performance and its use range is expanding year by year, not only the predetermined tilt angle but also the stability of the tilt angle is more important. From the viewpoint of the stability of the tilting angle, in the production step of the liquid crystal alignment film, it is proposed to contain a polyimine-based liquid crystal alignment treatment agent for the purpose of obtaining a certain inclination angle regardless of the honing condition. A compound having two or more epoxy groups in the molecule (for example, refer to the patent literature). Further, in the manufacturing step of the liquid crystal display device, in order to improve the alignment uniformity of the liquid crystal-5-200841093, there is a case where the liquid crystal is sealed and then heat-treated to cause the liquid crystal to be isotropy once, but the tilt angle is stable. When the degree of lowness is low, the tilt angle of the target size or the deviation of the tilt angle may not be obtained after the assimilation processing. In particular, in order to obtain high brightness, a liquid crystal display element using a backlight having a large amount of heat or a liquid crystal display element used in an in-vehicle use, such as a car navigation system and an instrument panel, may be used or placed in a long-time ambient temperature environment. In such a case, when the inclination angle is gradually changed under such severe conditions, the initial display characteristics may not be obtained, or the display may be uneven. [Problem to be Solved by the Invention] The present invention has been made in view of the above circumstances, and an object of the present invention is to provide a liquid crystal alignment treatment agent which is excellent in stability of a tilt angle even in a high-temperature environment for a long period of time, and provides a tilt. A liquid crystal display element having a small change in angle and excellent reliability of display. Further, with the recent increase in the density of pixels in the liquid crystal display element, the high dimensionality of the surface structure of the substrate (the large unevenness of the surface), the variation in the honing strength in the liquid crystal display surface is larger than that of the prior art, and occurs. In the weaker part, the alignment regulation force of the liquid crystal becomes weaker, and some display defects occur. Therefore, in addition to the stability of the lift angle, it is also an object of the present invention to provide a liquid crystal alignment treatment agent which does not deteriorate the alignment property of the liquid crystal regardless of the honing condition. 200841093 [Means for Solving the Problem] That is, the present invention is an invention having the following gist. (1) A liquid crystal alignment treatment agent comprising the following (A) component and (B) component, (A) at least one polymer selected from the group consisting of polyproline and polyimine. (B) A crosslinkable compound having at least two oxetanyl groups represented by the following formula [1] in the molecule. [Chemical 1]

(2 )如上述(1 )所記載之液晶配向處理劑,其中( B )成份爲下述式[2]所表示的化合物’(2) The liquid crystal alignment treatment agent according to the above (1), wherein the component (B) is a compound represented by the following formula [2]

[化2][Chemical 2]

(式[2]中,Χι 表示 N、NH、C0、0、S、S02、Si'倍半(In the formula [2], Χι means N, NH, C0, 0, S, S02, Si' 1/2

矽氧烷、聚矽氧烷、或碳數1〜2 0的有機基’此有機基中 亦可含有雜原子(N、0、s、Si) ; χ2及χ3各自獨立地 表示單鍵、ΝΗ、CO、Ο、S、S02、或碳數1〜20的有機基 ,此有機基中亦可含有雜原子(N、〇、S、Si) ;γι及Y2 200841093 各自獨立地表示碳數1〜2 0的有機基,此有機基中亦可含 有雜原子(Ν、0、S、Si ) ; m、η各自獨立地表示0〜2〇 的整數,且m + n表不2〜20的整數)。 (3 )如上述(1 )所記載之液晶配向處理劑,其中( B )成份爲下述式[3]所表示的化合物,A siloxane, a polyoxyalkylene, or an organic group having a carbon number of 1 to 20' may also contain a hetero atom (N, 0, s, Si) in the organic group; χ2 and χ3 each independently represent a single bond, ΝΗ , CO, hydrazine, S, S02, or an organic group having 1 to 20 carbon atoms, which may also contain a hetero atom (N, hydrazine, S, Si); γι and Y2 200841093 each independently represent a carbon number of 1~ An organic group of 20, the organic group may also contain a hetero atom (Ν, 0, S, Si); m, η each independently represent an integer of 0 to 2 ,, and m + n represents an integer of 2 to 20 ). (3) The liquid crystal alignment treatment agent according to the above (1), wherein the component (B) is a compound represented by the following formula [3],

(式[3]中,X2及X3各自獨立地表示單鍵、NH、C0、0、 S、S02、或碳數1〜20的有機基,此有機基中亦可含有雜 原子(N、0、S、Si) ;丫1及 Y2各自獨立地表示碳數 1〜20的有機基,此有機基中亦可含有雜原子(N、0、S、 Si ) ; Zi 表示單鍵、NH、N(CH3)、NHCO、CONH、 NHCONH、CO、COO、0、S、S02、CF2、C(CF3)2、 Si(CH3)2、OSi ( ch3 ) 2、Si ( ch3) 20、OSi ( ch3) 20、 或碳數1〜10的烷基;m、n各自獨立地表示0〜10的整數 ,且m + n表示2〜10的整數)。 (4 )如上述(1 )所記載之液晶配向處理劑,其中( B )成份爲下述式[4]所表示的化合物’ [化4] W⑷ -8- 200841093 (式[4]中,Χι 表示 NH、N ( CH3 ) 、NHCO、CONH、 NHCONH、CO、COO、OCO、0、S、S〇2、CF2、C(CF3)2 、Si ( CH3 ) 2、〇Si ( CH3 ) 2、Si ( CH3 ) 20、或 0Si(CH3)20; 丫!及Y2各自獨立地表示碳數1〜l〇的烷基) (5 )如上述(1 )所記載之液晶配向處理劑,其中( B )成份爲下述式[5]所表示的化合物’(In the formula [3], X2 and X3 each independently represent a single bond, NH, C0, 0, S, S02, or an organic group having 1 to 20 carbon atoms, and the organic group may also contain a hetero atom (N, 0). , S, Si); 丫1 and Y2 each independently represent an organic group having 1 to 20 carbon atoms, and the organic group may also contain a hetero atom (N, 0, S, Si); Zi represents a single bond, NH, N (CH3), NHCO, CONH, NHCONH, CO, COO, 0, S, S02, CF2, C(CF3)2, Si(CH3)2, OSi (ch3) 2, Si (ch3) 20, OSi (ch3) 20, or an alkyl group having 1 to 10 carbon atoms; m and n each independently represent an integer of 0 to 10, and m + n represents an integer of 2 to 10). (4) The liquid crystal alignment treatment agent according to the above (1), wherein the component (B) is a compound represented by the following formula [4] [Chemical Formula 4] W(4) -8- 200841093 (In the formula [4], Χι Represents NH, N (CH3), NHCO, CONH, NHCONH, CO, COO, OCO, 0, S, S〇2, CF2, C(CF3)2, Si(CH3) 2, 〇Si (CH3) 2, Si (CH3) 20 or 0Si(CH3)20; 丫! and Y2 each independently represent an alkyl group having 1 to 10 carbon atoms. (5) The liquid crystal alignment treatment agent according to (1) above, wherein (B) The composition is a compound represented by the following formula [5]

W匕5]W匕5]

[5] (式[5]中,Xi爲N、碳數1〜20的脂肪族環、碳數1〜20 的芳香族環或碳數1〜20的伸烷基;Y!及Y2各自獨立地表 示碳數1〜10的烷基;m、η各自獨立地表示0〜2 0的整數 ,且m + n表示2〜20的整數)。 (6 )上述(1 )〜(5 )中任一項所記載之液晶配向處 理劑,其中相對於該(A )成份1 00質量份,(B )成份含 量爲0.1〜150質量份。 (7 )上述(1)〜(6)中任一項所記載之液晶配向處 理劑,其係再含有有機溶劑。 (8 )上述(7 )所記載之液晶配向處理劑,其中該有 機溶劑係在總有機溶劑中含有5〜8〇質量%之具有低表面張 力的溶劑。 (9 )——種液晶配向膜,其係由上述(1 )〜(8 )中任 -9 - 200841093 一項所記載之液晶配向處理劑所得到。 (1 0 ) —種液晶顯示元件,其係具有上述(9 )所記 載之液晶配向膜。 [發明之效果] 藉由使用本發明的液晶配向處理劑,可得到即使在長 時間高溫環境下,傾斜角的安定性亦優異之液晶配向膜; 具有此液晶配向膜之液晶顯示元件,成爲信賴性優異者。 此外,本發明的液晶配向處理劑,因爲不易因爲硏磨而阻 礙聚合物的延伸性,以及對於弱的硏磨條件,液晶的配向 性亦不會降低,故特別適合使用於需要硏磨處理之用途。 [實施發明之最佳形態] < (A)成份:聚醯胺酸及聚醯亞胺> 本發明的液晶配向處理劑中,含有由聚醯胺酸及聚醯 亞胺所成的群中所選出的至少一種的聚合物,此聚醯胺酸 及聚醯亞胺的具體的結構並沒有特別的限制,例如習知的 液晶配向處理劑中所含有的聚醯胺酸或聚醯亞胺亦可。 聚醯胺酸可藉由四羧酸或四羧酸的衍生物、與二胺的 反應而得到。 本發明所使用的(A )成份之聚醯胺酸及聚醯亞胺的 製造方法無特別限制,一般而言,使由四羧酸及其衍生物 所選出的1種或複數種所成的四羧酸成份、與由1種或複 數種的二胺化合物所成的二胺成份進行反應,而得到聚醯 -10- 200841093 胺酸,使此聚醯胺酸進行釀亞胺化而成爲聚醯亞胺之方法 〇 此時,所得到的聚醯胺酸’可藉由適當選擇原料之四 羧酸成份與二胺成份’而成爲單聚物(homopolymer )或 共聚物(copolymer)。 此處,四羧酸及其衍生物,爲四羧酸、四羧酸二鹵化 物及四羧酸二酐,其中四羧酸二酐因爲與二胺化合物的反 應性高而較佳。 具體而言,可列舉均苯四甲酸、2,3,6,7 -萘四羧酸、 1,2,5,6-萘四羧酸、萘四羧酸、2,3,6,7_蒽四羧酸、 1,2,5,6-蒽四羧酸、3,3,,4,4、聯苯四羧酸、2,3,3,,4,-聯苯 四羧酸、雙(3,4-二羧基苯基)醚、3,3,,4,4,-二苯甲酮四 竣酸、雙(3,4-二羧基苯基)楓、雙(3,4-二羧基苯基) 甲院、2,2_雙(3,4_二羧基苯基)丙烷、υ,:ι,3,3,3-六氟-2,2-雙(3,4-二羧基苯基)丙烷、雙(3,4-二羧基苯基)二 甲基矽烷 '雙(3,4_二羧基苯基)二苯基矽烷、2,3,4,5-吡 陡四羧酸、2,6-雙(3,4-二羧基苯基)吡啶、2,2-雙[4-( 3,4-二羧基苯氧基)苯基]丙烷、3,3,,4,4,_二苯基礪四羧酸 、3,4,9,1〇-荘四羧酸、二苯基-;ι,2,3,4-環丁烷四羧酸 、氧代二酞醯四羧酸、1,2,3,4 -環丁烷四羧酸、1,2,3,4-環 戊院四羧酸、1,2,4,5-環己烷四羧酸、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸、1,2-二甲基-1,2,3,4-環丁烷四羧酸 、1,3-二甲基環丁烷四羧酸、12,3,4-環庚烷四羧 酸 2,3,4,5 -四氮咲喃四竣酸、3,4 -二駿基-1-環己基號拍 200841093 酸、2,3,5-三羧基環戊基乙酸、3,4-二羧基-1,2,3,4-四氫-1-萘琥珀酸、雙環[3,3,0]辛烷-2,4,6,8-四殘酸、雙環 [4,3,0]壬烷-2,4,7,9-四羧酸、雙環[4,4,〇]癸烷-2,4,7,9-四 羧酸、雙環[4,4,0]癸烷-2,4,8,10-四羧酸、三環[6.3.0.0< 2,6 > ]-[——烷-3,5,9,11-四羧酸、1,2,3,4 -丁烷四羧酸、雙 環[2,2,2]辛-7-烯-2,3,4,5·四羧酸、四環[6,2,1,1,0,2,7]十二 烷-4,5,9,1 0 ·四羧酸等之四羧酸。而且,可列舉此等的四羧 酸的二鹵化物及四羧酸二酐等。 特別是作爲液晶配向膜用途,由塗膜的透明性的觀點 而言,以脂環式四羧酸與此等的二酐及此等的二羧酸二酸 鹵化物爲佳,特別是以1,2,3,4_環丁烷四羧酸、2,3,5-三羧 基環戊基乙酸、3,4-二羧基-1,2,3,4-四氫-1-萘琥珀酸、雙 環[3,3,0]辛烷-2,4,6,8-四羧酸、及此等四羧酸的二鹵化物 、四羧酸的二酐較佳。 以上所舉例的四羧酸及其衍生物,依製成液晶配向膜 時的液晶配向性、電壓保持性、蓄積電荷等的特性,可使 用1種或混合2種以上使用。 聚醯胺酸的合成反應所使用的二胺,並沒有特別的限 制。 具體而言,可列舉Ρ-苯撐二胺、2,3,5,6-四甲基-Ρ-苯 撐二胺、2,5-二甲基-Ρ-苯撐二胺、m-苯撐二胺、2,4·二甲 基-m-苯撐二胺、2,5-二胺基甲苯、2,6-二胺基甲苯、2,5-二胺基苯酚、2,4-二胺基苯酚、3,5-二胺基苯酚、3,5_二胺 基苄基醇、2,4-二胺基苄基醇、4,6-二胺基苄基醇、4,4’- -12- 200841093 二胺基聯苯、3,3’-二甲基-4,4’-二胺基聯苯、3,3’-二甲氧 基-4,4’- _*胺基聯本、3,3’ - _*經基-4,4’- _^胺基聯苯、3,3’_ 二羧基-4,4’-二胺基聯苯、3,3’-二氟-4,4’-聯苯、3,3’-三氟 甲基-4,4’-二胺基聯苯、3,4’-二胺基聯苯、3,3’-二胺基聯 苯、2,2’-二胺基聯苯、2,3’-二胺基聯苯、4,4’-二胺基二 苯基甲烷、3,35-二胺基二苯基甲烷、3,4’-二胺基二苯基甲 烷、2,2’-二胺基二苯基甲烷、2,3’-二胺基二苯基甲烷、 4,4’-二胺基二苯基醚、3,3’-二胺基二苯基醚、3,4’-二胺 基二苯基醚、2,2’-二胺基二苯基醚、2,3’-二胺基二苯基醚 、4,4’-磺醯基二苯胺、3,3’-磺醯基二苯胺、雙(4-胺基苯 基)矽烷、雙(3-胺基苯基)矽烷、二甲基-雙(4-胺基苯 基)矽烷、二甲基-雙(3-胺基苯基)矽烷、4,4’-硫二苯 胺、3,3’-硫二苯胺、4,4’-二胺基二苯基胺、3,3’-二胺基 二苯基胺、3,4’-二胺基二苯基胺、2,2’-二胺基二苯基胺、 2,3’-二胺基二苯基胺、N_甲基(4,4’-二胺基二苯基)胺、 N-甲基(3,3’-二胺基二苯基)胺、N-甲基(3,4’-二胺基二 苯基)胺、N -甲基(2,2’_二胺基二苯基)胺、N_甲基( 2,3’-二胺基二苯基)胺、4,4’-二胺基二苯甲酮、3,3’-二 胺基二苯甲酮、3,4’-二胺基二苯甲酮、1,4-二胺基萘、 2,2’-二胺基二苯甲酮、2,3’-二胺基二苯甲酮、1,5·二胺基 萘、1,6-二胺基萘、1,7-二胺基萘、1,8-二胺基萘、2,5-二 胺基萘、2,6-二胺基萘、2,7-二胺基萘、2,8-二胺基萘、 1,2_雙(4-胺基苯基)乙烷、1,2-雙(3-胺基苯基)乙烷、 1,3_雙(4-胺基苯基)丙烷、1,3-雙(3-胺基苯基)丙烷、 -13- 200841093 1,4-雙(4-胺基苯基)丁烷、1,4-雙(3-胺基苯基)丁烷、 雙(3,5-二乙基-4-胺基苯基)甲烷、1,4-雙(4-胺基苯氧 基)苯、1,3-雙(4-胺基苯氧基)苯、1,4-雙(4-胺基苯基 )苯、1,3-雙(4-胺基苯基)苯、1,4-雙(4-胺基苄基)苯 、1,3-雙(4-胺基苯氧基)苯、4,4’-[1,4-伸苯基雙(伸甲 基)]二苯胺、4,4’-[1,3-伸苯基雙(伸甲基)]二苯胺、 3,4’-[1,4-伸苯基雙(伸甲基)]二苯胺、3,4’-[1,3-伸苯基 雙(伸甲基)]二苯胺、3,3’-[1,4-伸苯基雙(伸甲基)]二 苯胺、3,3’-[1,3-伸苯基雙(伸甲基)]二苯胺、1,4-伸苯 基雙[(4-胺基苯基)甲酮]、1,4-伸苯基雙[(3-胺基苯基 )甲酮]、1,3-伸苯基雙[(4-胺基苯基)甲酮1 ]、1,3-伸苯 基雙[(3-胺基苯基)甲酮]、1,4-伸苯基雙(4-胺基苯甲酸 酯)、1,4·伸苯基雙(3-胺基苯甲酸酯)、1,3-伸苯基雙 (4-胺基苯甲酸酯)、1,3-伸苯基雙(3-胺基苯甲酸酯) 、雙(4-胺基苯基)對苯二甲酸酯、雙(3-胺基苯基)對 苯二甲酸酯、雙(4-胺基苯基)間苯二甲酸酯、雙(3-胺 基苯基)間苯二甲酸酯、N,N’- ( 1,4-伸苯基)雙(4-胺基 苯醯胺)、N,N’·( 1,3-伸苯基)雙(4·胺基苯醯胺)、 N,N’- ( 1,4-伸苯基)雙(3-胺基苯醯胺)、Ν,Ν’- ( 1,3·伸 苯基)雙(3-胺基苯醯胺)、Ν,Ν’-雙(4-胺基苯基)對苯 二甲醯胺、Ν,Ν’-雙(3-胺基苯基)對苯二甲醯胺、Ν,Ν’-雙(4-胺基苯基)間苯二甲醯胺、Ν,Ν’-雙(3-胺基苯基) 間苯二甲醯胺、9,10-雙(4-胺基苯基)蒽、4,4’-雙(4-胺 基苯氧基)二苯基颯、2,2’-雙[4-(4-胺基苯氧基)苯基] -14 - 200841093 丙烷、2,2’_雙[4_ (4-胺基苯氧基)苯基]六氟丙烷、2,2’-雙(4-胺基苯基)六氣丙院、2,2’-雙(3 -胺基苯基)六氯 丙烷、2,2’-雙(3-胺基-4-甲基苯基)六氟丙烷、2,2’-雙 (4-胺基苯基)丙烷、2,2’-雙(3-胺基苯基)丙烷、2,2’-雙(3-胺基-4-甲基苯基)丙烷、3.5-二胺基苯甲酸、2,5-二胺基苯甲酸、1,3-雙(4_胺基苯氧基)丙烷、1,3-雙(3-胺基苯氧基)丙烷、1,4-雙(4-胺基苯氧基)丁烷、1,4-雙(3-胺基苯氧基)丁烷、1,5-雙(4-胺基苯氧基)戊烷 、1,5-雙(3-胺基苯氧基)戊烷、1,6_雙(4-胺基苯氧基) 己烷、1,6-雙(3-胺基苯氧基)己烷、1,7-雙(4-胺基苯氧 基)庚烷、1,7·雙(3-胺基苯氧基)庚烷、1,8-雙(4-胺基 苯氧基)辛烷、1,8-雙(3-胺基苯氧基)辛烷、1,9-雙(4-胺基苯氧基)壬烷、1,9-雙(3-胺基苯氧基)壬烷、1,10-雙(4-胺基苯氧基)癸烷、1,1〇-(3_胺基苯氧基)癸烷、 1,11-(4-胺基苯氧基)十一烷、胺基苯氧基)十 一烷、1,12-(4 -胺基苯氧基)十二烷、1,12_(3_胺基苯氧 基)十二烷等之芳香族二胺;雙(4-胺基環己基)甲烷、 雙(4-胺基-3-甲基環己基)甲烷等之脂環式二胺;ι,3-二 胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6 -二胺基 己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷 、1,10-二胺基癸烷、1,11-二胺基十一烷酯、1,12-二胺基 十二烷酯等之脂肪族二胺等。 此外,可列舉二胺側鏈上具有烷基、含氟烷基、芳香 環、脂肪族環、雜環、及由此等所成的大環狀取代物。具 -15- 200841093 體而言,可列舉下述式[A1]〜[A20]所表示的二胺。 [{匕6][5] (In the formula [5], Xi is N, an aliphatic ring having 1 to 20 carbon atoms, an aromatic ring having 1 to 20 carbon atoms or an alkylene group having 1 to 20 carbon atoms; Y! and Y2 are each independently The ground represents an alkyl group having 1 to 10 carbon atoms; m and η each independently represent an integer of 0 to 2 0, and m + n represents an integer of 2 to 20). (6) The liquid crystal alignment agent according to any one of the above (1), wherein the component (B) is contained in an amount of 0.1 to 150 parts by mass based on 100 parts by mass of the component (A). (7) The liquid crystal alignment agent according to any one of (1) to (6) above which further contains an organic solvent. (8) The liquid crystal alignment treatment agent according to the above (7), wherein the organic solvent contains 5 to 8 % by mass of a solvent having a low surface tension in the total organic solvent. (9) A liquid crystal alignment film obtained by the liquid crystal alignment treatment agent according to any one of the above (1) to (8). (10) A liquid crystal display device comprising the liquid crystal alignment film described in the above (9). [Effects of the Invention] By using the liquid crystal alignment treatment agent of the present invention, a liquid crystal alignment film having excellent stability of a tilt angle even in a high-temperature environment for a long period of time can be obtained, and a liquid crystal display element having the liquid crystal alignment film can be trusted. Excellent sex. Further, the liquid crystal alignment treatment agent of the present invention is particularly suitable for use in honing treatment because it is difficult to hinder the elongation of the polymer by honing, and the alignment property of the liquid crystal is not lowered for weak honing conditions. use. [Best Mode for Carrying Out the Invention] < (A) Component: Polyproline and Polyimine] The liquid crystal alignment treatment agent of the present invention contains a group of polyglycine and polyimine The specific structure of the at least one polymer selected, the polyamic acid and the polyimine is not particularly limited, and is, for example, a polyamic acid or a polyphthalamide contained in a conventional liquid crystal alignment treatment agent. Amines are also available. Polylysine can be obtained by a reaction of a derivative of a tetracarboxylic acid or a tetracarboxylic acid with a diamine. The method for producing the polyamine and the polyimine of the component (A) used in the present invention is not particularly limited, and generally, one or more selected from the group consisting of tetracarboxylic acid and a derivative thereof are used. The tetracarboxylic acid component is reacted with a diamine component formed from one or more kinds of diamine compounds to obtain a polyfluorene-10-200841093 aminic acid, which is subjected to amination of the polyamic acid to form a poly Method of quinone imine In this case, the obtained polyglycolic acid ' can be a homopolymer or a copolymer by appropriately selecting a tetracarboxylic acid component and a diamine component of the raw material. Here, the tetracarboxylic acid and its derivative are a tetracarboxylic acid, a tetracarboxylic acid dihalogen, and a tetracarboxylic dianhydride, and among them, a tetracarboxylic dianhydride is preferred because it has high reactivity with a diamine compound. Specific examples thereof include pyromellitic acid, 2,3,6,7-naphthalenetetracarboxylic acid, 1,2,5,6-naphthalenetetracarboxylic acid, naphthalenetetracarboxylic acid, 2,3,6,7_ Terpene tetracarboxylic acid, 1,2,5,6-nonanetetracarboxylic acid, 3,3,4,4,biphenyltetracarboxylic acid, 2,3,3,,4,-biphenyltetracarboxylic acid, double (3,4-dicarboxyphenyl)ether, 3,3,4,4,-benzophenone tetradecanoic acid, bis(3,4-dicarboxyphenyl) maple, bis(3,4-di Carboxyphenyl) Azolla, 2,2_bis(3,4-dicarboxyphenyl)propane, anthracene, :,3,3,3-hexafluoro-2,2-bis(3,4-dicarboxyl Phenyl)propane, bis(3,4-dicarboxyphenyl)dimethyl decane 'bis(3,4-dicarboxyphenyl)diphenyl decane, 2,3,4,5-pyrrolidinetetracarboxylic acid , 2,6-bis(3,4-dicarboxyphenyl)pyridine, 2,2-bis[4-(3,4-dicarboxyphenoxy)phenyl]propane, 3,3,4,4 , _ diphenyl sulfonium tetracarboxylic acid, 3,4,9,1 fluorene tetracarboxylic acid, diphenyl-; i, 2,3,4-cyclobutane tetracarboxylic acid, oxodisium tetra Carboxylic acid, 1,2,3,4-cyclobutanetetracarboxylic acid, 1,2,3,4-cyclopentene tetracarboxylic acid, 1,2,4,5-cyclohexanetetracarboxylic acid, 1, 2,3,4-Tetramethyl-1,2,3,4-cyclobutanetetracarboxylic acid, 1,2-dimethyl-1,2, 3,4-cyclobutanetetracarboxylic acid, 1,3-dimethylcyclobutanetetracarboxylic acid, 12,3,4-cycloheptanetetracarboxylic acid 2,3,4,5-tetraazaindole Citrate, 3,4-diphenyl-1-cyclohexyl number 200841093 acid, 2,3,5-tricarboxycyclopentyl acetic acid, 3,4-dicarboxy-1,2,3,4-tetrahydrogen 1-naphthylsuccinic acid, bicyclo[3,3,0]octane-2,4,6,8-tetraresidic acid, bicyclo[4,3,0]nonane-2,4,7,9-tetra Carboxylic acid, bicyclo[4,4,nonane]nonane-2,4,7,9-tetracarboxylic acid, bicyclo[4,4,0]nonane-2,4,8,10-tetracarboxylic acid, three Ring [6.3.0.0 < 2,6 > ]-[-alkane-3,5,9,11-tetracarboxylic acid, 1,2,3,4-butanetetracarboxylic acid, bicyclo[2,2 , 2] oct-7-ene-2,3,4,5·tetracarboxylic acid, tetracyclo[6,2,1,1,0,2,7]dodecane-4,5,9,1 0 A tetracarboxylic acid such as tetracarboxylic acid. Further, examples thereof include dihalides of tetracarboxylic acid and tetracarboxylic dianhydride. In particular, as a liquid crystal alignment film, from the viewpoint of transparency of the coating film, alicyclic tetracarboxylic acid and such dianhydrides and such dicarboxylic acid diacid halides are preferred, particularly 1 , 2,3,4_cyclobutane tetracarboxylic acid, 2,3,5-tricarboxycyclopentyl acetic acid, 3,4-dicarboxy-1,2,3,4-tetrahydro-1-naphthalene succinic acid Bicyclo[3,3,0]octane-2,4,6,8-tetracarboxylic acid, and dihalides of such tetracarboxylic acids and dianhydrides of tetracarboxylic acids are preferred. The tetracarboxylic acid and the derivative thereof, which are exemplified above, may be used alone or in combination of two or more kinds depending on the characteristics of liquid crystal alignment, voltage retention, and charge accumulation in the liquid crystal alignment film. The diamine used in the synthesis reaction of polylysine is not particularly limited. Specific examples thereof include anthracene-phenylenediamine, 2,3,5,6-tetramethyl-anthracene-phenylenediamine, 2,5-dimethyl-anthracene-phenylenediamine, and m-benzene. Diamine, 2,4·dimethyl-m-phenylenediamine, 2,5-diaminotoluene, 2,6-diaminotoluene, 2,5-diaminophenol, 2,4- Diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2,4-diaminobenzyl alcohol, 4,6-diaminobenzyl alcohol, 4,4 '- -12- 200841093 Diaminobiphenyl, 3,3'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'- _* amine Base, 3,3' - _*-based 4,4'- _aminobiphenyl, 3,3'-dicarboxy-4,4'-diaminobiphenyl, 3,3'- Difluoro-4,4'-biphenyl, 3,3'-trifluoromethyl-4,4'-diaminobiphenyl, 3,4'-diaminobiphenyl, 3,3'-diamine Biphenyl, 2,2'-diaminobiphenyl, 2,3'-diaminobiphenyl, 4,4'-diaminodiphenylmethane, 3,35-diaminodiphenylmethane , 3,4'-diaminodiphenylmethane, 2,2'-diaminodiphenylmethane, 2,3'-diaminodiphenylmethane, 4,4'-diaminodiphenyl Ether, 3,3'-diaminodiphenyl ether, 3,4'-diaminodiphenyl , 2,2'-diaminodiphenyl ether, 2,3'-diaminodiphenyl ether, 4,4'-sulfonyldiphenylamine, 3,3'-sulfonyldiphenylamine, double (4-Aminophenyl)decane, bis(3-aminophenyl)decane, dimethyl-bis(4-aminophenyl)decane, dimethyl-bis(3-aminophenyl)decane , 4,4'-thiodiphenylamine, 3,3'-thiodiphenylamine, 4,4'-diaminodiphenylamine, 3,3'-diaminodiphenylamine, 3,4'- Diaminodiphenylamine, 2,2'-diaminodiphenylamine, 2,3'-diaminodiphenylamine, N-methyl (4,4'-diaminodiphenyl Amine, N-methyl(3,3'-diaminodiphenyl)amine, N-methyl(3,4'-diaminodiphenyl)amine, N-methyl (2,2' _Diaminodiphenyl)amine, N-methyl(2,3'-diaminodiphenyl)amine, 4,4'-diaminobenzophenone, 3,3'-diamino Benzophenone, 3,4'-diaminobenzophenone, 1,4-diaminonaphthalene, 2,2'-diaminobenzophenone, 2,3'-diaminodiphenyl Methyl ketone, 1,5-diaminonaphthalene, 1,6-diaminonaphthalene, 1,7-diaminonaphthalene, 1,8-diaminonaphthalene, 2,5-diaminonaphthalene, 2, 6-diamino group , 2,7-diaminonaphthalene, 2,8-diaminonaphthalene, 1,2-bis(4-aminophenyl)ethane, 1,2-bis(3-aminophenyl)ethane 1,3_bis(4-aminophenyl)propane, 1,3-bis(3-aminophenyl)propane, -13- 200841093 1,4-bis(4-aminophenyl)butane , 1,4-bis(3-aminophenyl)butane, bis(3,5-diethyl-4-aminophenyl)methane, 1,4-bis(4-aminophenoxy) Benzene, 1,3-bis(4-aminophenoxy)benzene, 1,4-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophenyl)benzene, 1, 4-bis(4-aminobenzyl)benzene, 1,3-bis(4-aminophenoxy)benzene, 4,4'-[1,4-phenylene bis(methyl)methyl Aniline, 4,4'-[1,3-phenylenebis(methyl)diphenylamine, 3,4'-[1,4-phenylenebis(methyl)diphenylamine, 3, 4'-[1,3-phenylenebis(methyl)diphenylamine, 3,3'-[1,4-phenylenebis(methyl)diphenylamine, 3,3'-[ 1,3-phenylene bis(methyl)diphenylamine, 1,4-phenylene bis[(4-aminophenyl)methanone], 1,4-phenylene bis[(3- Aminophenyl)methanone], 1,3-phenylene bis[(4-aminophenyl) Ketone 1 ], 1,3-phenylene bis[(3-aminophenyl)methanone], 1,4-phenylene bis(4-aminobenzoate), 1,4·benzene Bis(3-aminobenzoate), 1,3-phenylene bis(4-aminobenzoate), 1,3-phenylene bis(3-aminobenzoate) , bis(4-aminophenyl)terephthalate, bis(3-aminophenyl)terephthalate, bis(4-aminophenyl)isophthalate, double (3-Aminophenyl)isophthalate, N,N'-(1,4-phenylene)bis(4-aminophenylguanamine), N,N'·( 1,3- Phenyl)bis(4.aminoamidoamine), N,N'-(1,4-phenylene)bis(3-aminophenylguanamine), hydrazine, Ν'- (1,3· Phenyl) bis(3-aminophenylguanamine), hydrazine, Ν'-bis(4-aminophenyl)terephthalamide, hydrazine, Ν'-bis(3-aminophenyl) Parathylene phthalamide, hydrazine, Ν'-bis(4-aminophenyl)m-xylylene amide, hydrazine, Ν'-bis(3-aminophenyl)m-xylyleneamine, 9 , 10-bis(4-aminophenyl)anthracene, 4,4'-bis(4-aminophenoxy)diphenylanthracene, 2,2'-bis[4-(4-aminobenzene) Phenyl] -14 - 200841093 propane, 2,2'-bis[4_(4-aminophenoxy)phenyl]hexafluoropropane, 2,2'-bis(4-aminophenyl)hexa Qibin, 2,2'-bis(3-aminophenyl)hexachloropropane, 2,2'-bis(3-amino-4-methylphenyl)hexafluoropropane, 2,2'- Bis(4-aminophenyl)propane, 2,2'-bis(3-aminophenyl)propane, 2,2'-bis(3-amino-4-methylphenyl)propane, 3.5- Diaminobenzoic acid, 2,5-diaminobenzoic acid, 1,3-bis(4-aminophenoxy)propane, 1,3-bis(3-aminophenoxy)propane, 1, 4-bis(4-aminophenoxy)butane, 1,4-bis(3-aminophenoxy)butane, 1,5-bis(4-aminophenoxy)pentane, 1 , 5-bis(3-aminophenoxy)pentane, 1,6-bis(4-aminophenoxy)hexane, 1,6-bis(3-aminophenoxy)hexane, 1,7-bis(4-aminophenoxy)heptane, 1,7-bis(3-aminophenoxy)heptane, 1,8-bis(4-aminophenoxy)octane 1,8-bis(3-aminophenoxy)octane, 1,9-bis(4-aminophenoxy)decane, 1,9-bis(3-aminophenoxy)anthracene Alkane, 1,1 0-bis(4-aminophenoxy)decane, 1,1 fluorene-(3-aminophenoxy)decane, 1,11-(4-aminophenoxy)undecane, amine Aromatic diamines such as phenoxy)undecane, 1,12-(4-aminophenoxy)dodecane, 1,12-(3-aminophenoxy)dodecane; 4-aminocyclohexyl)methane, alicyclic diamine such as bis(4-amino-3-methylcyclohexyl)methane; iota, 3-diaminopropane, 1,4-diaminobutane 1,5-diaminopentane, 1,6-diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminodecane An aliphatic diamine such as 1,10-diaminodecane, 1,11-diaminoundecyl ester or 1,12-diaminododecyl ester. Further, examples of the diamine side chain include an alkyl group, a fluorine-containing alkyl group, an aromatic ring, an aliphatic ring, a hetero ring, and a large cyclic substituent formed therefrom. The diamine represented by the following formulas [A1] to [A20] is exemplified as the -15-200841093. [{匕6]

H2NH2N

[A1][A1]

(式[A1]〜[A 5]中,1^表示碳數1以上22以下的烷基或含 氟烷基)。 -16- 200841093 [化7](In the formulae [A1] to [A5], 1^ represents an alkyl group having 1 or more and 22 or less carbon atoms or a fluorine-containing alkyl group). -16- 200841093 [化7]

[A6] CA7][A6] CA7]

(式[A6]〜[A9]中,R2 表示 COO、OCO、CONH、 CH2、0、C0、或NH;R3表示氫原子、碳數1I^ 下的烷基或含氟烷基)。 NHCO、 上22以(In the formula [A6] to [A9], R2 represents COO, OCO, CONH, CH2, 0, C0, or NH; and R3 represents a hydrogen atom, an alkyl group having a carbon number of 1I^ or a fluorine-containing alkyl group). NHCO, on 22

17- 200841093 (式[A10]〜[All]中,R4 表示 〇、〇CH2、CH20、COOCH2 、或CH2OCO ; R5表示碳數1以上22以下的烷基、烷氧 基、含氟烷基或含氟烷氧基)。 [fW]17- 200841093 (In the formula [A10] to [All], R4 represents 〇, 〇CH2, CH20, COOCH2, or CH2OCO; R5 represents an alkyl group having 1 to 22 or less carbon atoms, an alkoxy group, a fluorine-containing alkyl group or a Fluoroalkoxy). [fW]

(式[A12]〜[A14]中,R5 表示 COO、OCO、CONH、NHCO 、COOCH2、CH2OCO、CH20、OCH2、或 CH2; R7 表示碳 數1以上22以下的烷基、烷氧基、含氟烷基或含氟烷氧 基)。 -18- 200841093(In the formula [A12] to [A14], R5 represents COO, OCO, CONH, NHCO, COOCH2, CH2OCO, CH20, OCH2, or CH2; and R7 represents an alkyl group having 1 or more and 22 or less carbon atoms, an alkoxy group, or a fluorine-containing group. Alkyl or fluoroalkoxy). -18- 200841093

UtlQl Η2Ν^8Ό^9 Ci nh2 Η2ΝΧ>»ΟΌ^ NHCO NH ; 醯基、 (式[A15]〜[A16]中,R8 表示 COO' OCO、CONH、 、COOCH2、CH2OCO、CH20、OCH2、CH2、Ο、或 r9表示氟基、氰基、三氟甲基、硝基、偶氮基、甲 乙醯基、乙醯氧基、羥基、或羧基)。 -19- 200841093 W 匕 11]UtlQl Η2Ν^8Ό^9 Ci nh2 Η2ΝΧ>»ΟΌ^ NHCO NH ; 醯 base, (in the formula [A15]~[A16], R8 represents COO' OCO, CONH, COOCH2, CH2OCO, CH20, OCH2, CH2, Ο Or r9 represents a fluoro group, a cyano group, a trifluoromethyl group, a nitro group, an azo group, a methyl ethyl fluorenyl group, an ethyl ethoxy group, a hydroxyl group, or a carboxyl group). -19- 200841093 W 匕 11]

基矽氧烷等。 [A2 1] 而且,可列舉如下述式[A21]所表示的二胺 [化 12] /ch3\ ch3 H2N一(CH2)3十甲-夺一(CH2)3_NH2 \CH3/mCH3 (式[A2 1]中,m表示1〜10的整數)。 上述的二胺,依製成液晶配向膜時的液晶配向性、電 -20- 200841093 壓保持性、蓄積電荷等的特性,可使用1種或混合2種以 上使用。 上述所示的聚醯胺酸的合成原料之中,使用具有羥基 或羧基之原料’則可提高聚醯胺酸或聚醯亞胺與後述的交 聯性化合物的反應效率。如此的原料的具體例子,可列舉 2,5-二胺基苯酚、2,4-二胺基苯酚、3,5-二胺基苯酚、3,5-二胺基苄基醇、2,4-二胺基苄基醇、3,3’·二羥基-4,4,-二 胺基聯苯、3,3’-二羧基_4,4’_二胺基聯苯、3,5_二胺基苯 甲酸、2,5-二胺基苯甲酸、式[A22]〜[A25]所表示的二胺等 [化 13]Base oxane and the like. [A2 1] Further, a diamine represented by the following formula [A21]: [12] /ch3\ch3 H2N-(CH2)3-deca----(CH2)3_NH2\CH3/mCH3 (Formula [A2] In 1], m represents an integer of 1 to 10). The diamine can be used in one type or in a mixture of two or more types depending on the liquid crystal alignment property, the liquid-retentive property of the liquid crystal alignment film, and the charge retention property. Among the synthetic raw materials of polylysine shown above, the use of a raw material having a hydroxyl group or a carboxyl group can improve the reaction efficiency of polyperuric acid or polyimine with a crosslinkable compound to be described later. Specific examples of such a raw material include 2,5-diaminophenol, 2,4-diaminophenol, 3,5-diaminophenol, 3,5-diaminobenzyl alcohol, 2, 4 -diaminobenzyl alcohol, 3,3'. dihydroxy-4,4,-diaminobiphenyl, 3,3'-dicarboxy-4,4'-diaminobiphenyl, 3,5_ Diaminobenzoic acid, 2,5-diaminobenzoic acid, diamine represented by the formula [A22] to [A25], etc. [Chem. 13]

[A2 2] [A2 3][A2 2] [A2 3]

ΓΑ2 4]ΓΑ 2 4]

-21 - 200841093-21 - 200841093

(式[A22]〜[A25]中,R1()表示 COO、OCO、CONH、NHCO 、CH2、Ο、CO、或 NH )。(In the formula [A22] to [A25], R1() represents COO, OCO, CONH, NHCO, CH2, Ο, CO, or NH).

[A2 7] (式[A26]及[A27]中,Rn 表示 COO、OCO、CONH、 NHCO、COOCH2、CH2OCO、CH20、OCH2、CH2、Ο、或 NH ; R12表示羥基、或羧基)。 合成聚醯胺酸時所使用的有機溶劑,只要是溶解所生 成的聚醯胺酸者即可,並沒有特別的限制。若列舉其具體 例子,爲N,N-二甲基甲醯胺、N,N-二甲基乙醯胺、N-甲 基-2-吡咯烷酮、N-甲基己內醯胺、二甲基亞礪、四甲基 尿素、吡啶、二甲基颯、六甲基亞礪、7-丁內酯、異丙 醇、甲氧基甲基戊醇、二戊烯、乙基胺基酮、甲基壬基酮 、甲基乙基酮、甲基異戊基酮、甲基異丙基酮、甲基溶纖 劑、乙基溶纖劑、甲基溶纖劑乙酸酯、乙基溶纖劑乙酸酯 、丁基卡必醇、乙基卡必醇、乙二醇、乙二醇單乙酸酯、 乙二醇單異丙醚、乙二醇單丁醚、丙二醇、丙二醇單乙酸 酯、丙二醇單曱醚、丙二醇-tert-丁醚、二丙二醇單甲醚 -22- 200841093 、二乙二醇、二乙二醇單乙酸酯、二乙二醇二甲醚、二丙 二醇單乙酸酯單甲醚、二丙二醇單甲醚、二丙二醇單乙醚 、二丙二醇單乙酸酯單乙醚、二丙二醇單丙醚、二丙二醇 單乙酸酯單丙醚、3·甲基-甲氧基丁基乙酸酯、三丙二醇甲 醚、3-甲基-3-甲氧基丁醇、二異丙醚、乙基異丁醚、二異 丁烯、戊基乙酸酯、丁基丁酸酯、丁醚、二異丁基酮、甲 基環己烯、丙醚、二己醚、二噁烷、n_己烷、η-戊烷、η-辛烷、二乙醚、環己酮、乙烯碳酸酯、丙烯碳酸酯、乳酸 甲酯、乳酸乙酯、乙酸甲酯、乙酸乙酯、乙酸η-丁酯、乙 酸丙二醇單乙醚、丙酮酸甲酯、丙酮酸乙酯、3_甲氧基丙 酮酸甲酯、3 -乙氧基丙酮酸甲基乙酯、3_甲氧基丙酸乙酯 、3-乙氧基丙酸、3-甲氧基丙酸、3-甲氧基丙酸丙酯、3-甲氧基丙酸丁酯、二甘醇二甲醚、4-羥基-4-甲基-2-戊酮 ;此等可單獨使用,或可混合使用。而且,即使爲不溶解 聚醯胺酸之溶劑’在所生成的聚醯胺酸未析出的範圍,亦 可混合於上述溶劑中使用。此外,因爲有機溶劑中的水分 阻礙聚合反應,而成爲進一步水解所生成的聚醯胺酸的原 因,故有機溶劑儘可能使用經脫水乾燥者。 使合成聚醯胺酸時之四羧酸及其衍生物與二胺在有機 溶劑中進行反應之方法,可列舉攬拌將二胺分散或溶解於 有機溶劑的溶液,直接添加四羧酸及其衍生物,或者使其 分散或溶解於有機溶劑後添加之方法;相反地在使四竣酸 及其衍生物分散或溶解於有機溶劑的溶液中添加二胺之方 法;交替地添加四羧酸及其衍生物與二胺之方法等。此等 -23· 200841093 可爲任何一種方法,此外,由四羧酸及其衍生物或二胺爲 複數種的化合物所成時,以預先混合的狀態使其反應亦可 ,個別地依序反應亦可,而且使個別經反應所成的低分子 量物進行混合反應所成的高分子量物亦可。 合成聚醯胺酸時的溫度可選擇-2 0 °C〜1 5 〇 °C的任意的 溫度,較佳爲-5 °C〜1〇〇 °C的範圍,此外,反應可用任意的 濃度進行,但濃度太低則很難得到高分子量的聚合物,濃 度太高則因爲反應液的黏性變太高而均勻地攪拌變難,故 較佳爲1〜50質量%,更佳爲5〜30質量%。反應初期以高 濃度進行,然後,亦可追加有機溶劑。 於聚醯胺酸的合成中,相對於四羧酸及其衍生物的莫 耳數,二胺成份的莫耳收的比爲0.8〜1.2較佳,0.9〜1.1爲 更佳。與通常的聚縮合反應同樣,此莫耳比愈接近1·〇, 所生成的聚醯胺酸的分子量愈大。 使聚醯胺酸進行聚醯亞胺化之方法,藉由加熱之熱醯 亞胺化、使用觸媒之觸媒醯亞胺化爲一般方法,以比較低 溫進行醯亞胺化之觸媒化的方法,因爲不易引起所得到的 聚醯亞胺的分子量降低而較佳。 觸媒醯亞胺化,係可於有機溶劑中,在鹼性觸媒與酸 酐的存在下藉由.攬拌聚醯胺酸而進行。此時的反應溫度 爲-20〜250°C,較佳爲〇〜18〇°C。反應溫度較高則醯亞胺化 較快進行,但太高則會有聚醯亞胺的分子量降低的情況, 鹼性觸媒的量爲醯胺酸基的〇·5〜30莫耳倍,較佳爲2〜20 莫耳倍,酸酐的量爲醯胺酸基的1〜5 〇莫耳倍’較佳爲 -24- 200841093 3〜3 0莫耳倍。鹼性觸媒或酸酐的量少則反應未充分地被進 行,此外太多則反應結束後很難被完全去除。 鹼性觸媒可列舉吡啶、三乙胺、三甲胺、三丁胺、三 辛胺等,其中吡啶因爲具有使反應進行之適度的鹼性而較 佳。此外,酸酐可列舉乙酸酐、偏苯三酸酐、均苯四甲酸 等,其中又以使用乙酸酐,因爲反應結束後的純化變容易 而較佳。 作爲有機溶劑,只要是聚醯胺酸者即可,並沒有特別 限定,若列舉其具體例子,有Ν,Ν’-二甲基甲醯胺、Ν,Ν’_ 二甲基乙醯胺、Ν-甲基-2-吡咯烷酮、Ν-甲基己內醯胺、 二甲基亞颯、四甲基尿素、二甲基颯、六甲基亞楓、Τ-丁內酯等。藉由觸媒醯亞胺化之醯亞胺化率,藉由調節觸 媒量與反應溫度、反應時間進行控制。 所生成的聚醯亞胺,係藉由回收將上述反應溶液投入 弱溶劑後所生成的沈澱而得到。此時,所使用的弱溶劑並 沒有特別的限定,但可列舉例如甲醇、丙酮、己烷、丁基 溶纖劑、庚烷、甲基乙基酮、甲基異丁基酮、乙醇、甲苯 、苯、水等。投入弱溶劑後被沈澱之聚醯亞胺,經過濾後 ’在常壓或減壓下,常溫或加熱乾燥後可使其成爲粉末, 此聚醯亞胺粉末,再溶解於有機溶劑中後再沈澱之步驟重 複2〜1 0次,可純化聚醯亞胺。一次的沈澱回收操作無法 去除雜質時,進行此純化步驟較佳。 本發明所使用的特定聚醯亞胺的分子量並沒特別的限 定’但由操作容易度、膜形成時的特性的安定性的觀點而 -25- 200841093 言,以重量平均分子量爲2,000〜200,000爲佳,更佳爲 4,00 0〜5 0,000。分子量爲由GPC (凝膠滲透層析法)所計 算得到。 < (B)成份:特定交聯性化合物> 本發明的液晶配向處理劑,除了上述聚合物成份,尙 含有分子內中具有至少2個下述式[1]所表示的氧雜環丁烷 基之交聯性化合物 (B)分子內中具有至少2個下述式[1]所表示的氧雜 環丁烷基之交聯性化合物(以下稱爲特定交聯性化合物) Μ 匕 15][A2 7] (In the formula [A26] and [A27], Rn represents COO, OCO, CONH, NHCO, COOCH2, CH2OCO, CH20, OCH2, CH2, Ο, or NH; R12 represents a hydroxyl group or a carboxyl group). The organic solvent to be used in the synthesis of the polyamic acid is not particularly limited as long as it is a polylysine which is produced by dissolution. Specific examples thereof include N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone, N-methylcaprolactam, dimethyl Azulene, tetramethyl urea, pyridine, dimethyl hydrazine, hexamethylarylene, 7-butyrolactone, isopropanol, methoxymethylpentanol, dipentene, ethylamino ketone, A Ketrinone, methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, methyl cellosolve, ethyl cellosolve, methyl cellosolve acetate, ethyl cellosolve Acetate, butyl carbitol, ethyl carbitol, ethylene glycol, ethylene glycol monoacetate, ethylene glycol monoisopropyl ether, ethylene glycol monobutyl ether, propylene glycol, propylene glycol monoacetic acid Ester, propylene glycol monoterpene ether, propylene glycol-tert-butyl ether, dipropylene glycol monomethyl ether-22- 200841093, diethylene glycol, diethylene glycol monoacetate, diethylene glycol dimethyl ether, dipropylene glycol single B Acid ester monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetate monopropyl ether, 3·methyl-methoxy Butyl acetate, tripropyl Alcohol methyl ether, 3-methyl-3-methoxybutanol, diisopropyl ether, ethyl isobutyl ether, diisobutylene, pentyl acetate, butyl butyrate, dibutyl ether, diisobutyl Ketone, methylcyclohexene, propyl ether, dihexyl ether, dioxane, n-hexane, η-pentane, η-octane, diethyl ether, cyclohexanone, ethylene carbonate, propylene carbonate, lactic acid Methyl ester, ethyl lactate, methyl acetate, ethyl acetate, η-butyl acetate, propylene glycol monoethyl ether, methyl pyruvate, ethyl pyruvate, methyl 3-methoxyacetonate, 3-ethoxy Methyl ethyl pyruvate, ethyl 3-methoxypropionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate, 3-methoxypropane Butyl acrylate, diglyme, 4-hydroxy-4-methyl-2-pentanone; these may be used singly or in combination. Further, even in the range in which the produced polyamine acid is not precipitated in the range in which the polyamic acid is not dissolved, it can be used in the above solvent. Further, since the water in the organic solvent hinders the polymerization reaction and becomes a cause of further hydrolysis of the produced polyamic acid, the organic solvent is used as far as possible for dehydration. A method for reacting a tetracarboxylic acid and a derivative thereof in an organic solvent in the synthesis of polyamic acid, and a solution in which a diamine is dispersed or dissolved in an organic solvent, and a tetracarboxylic acid is directly added thereto a derivative, or a method of adding it after dispersing or dissolving in an organic solvent; instead, adding a diamine to a solution in which tetradecanoic acid and a derivative thereof are dispersed or dissolved in an organic solvent; alternately adding a tetracarboxylic acid and The method of the derivative and the diamine, and the like. These -23· 200841093 may be any method, and when the tetracarboxylic acid and its derivative or diamine are a plurality of compounds, the reaction may be carried out in a premixed state, and the reaction may be carried out individually. Further, a high molecular weight product obtained by subjecting a plurality of low molecular weight substances formed by the reaction to a mixed reaction may be used. The temperature at which the polyamic acid is synthesized may be selected from any temperature of from -2 °C to 15 °C, preferably from -5 °C to 1 °C, and the reaction may be carried out at any concentration. However, if the concentration is too low, it is difficult to obtain a polymer having a high molecular weight. If the concentration is too high, the viscosity of the reaction liquid becomes too high and the stirring is difficult, so it is preferably 1 to 50% by mass, more preferably 5 to 5. 30% by mass. The initial stage of the reaction is carried out at a high concentration, and then an organic solvent may be added. In the synthesis of polyamic acid, the molar ratio of the diamine component to the molar ratio of the tetracarboxylic acid and the derivative thereof is preferably 0.8 to 1.2, more preferably 0.9 to 1.1. As with the usual polycondensation reaction, the closer the molar ratio is to 1 〇, the larger the molecular weight of the produced polyamine. A method for polyimidization of polylysine by means of a heated hydrazine imidization, a catalyst oxime imidization using a catalyst as a general method, and a catalytication of ruthenium imidization at a relatively low temperature The method is preferred because it does not easily cause a decrease in the molecular weight of the obtained polyimine. The imidization of the catalyst oxime can be carried out by mixing the polyamic acid in an organic solvent in the presence of a basic catalyst and an acid anhydride. The reaction temperature at this time is -20 to 250 ° C, preferably 〇 18 〇 ° C. When the reaction temperature is high, the imidization is carried out faster, but if it is too high, the molecular weight of the polyimine is lowered, and the amount of the basic catalyst is 醯·5 to 30 mol times of the proline group. Preferably, it is 2 to 20 moles, and the amount of the acid anhydride is 1 to 5 moles of the valeric acid group, preferably -24 to 200841093 3 to 3 0 moles. When the amount of the basic catalyst or acid anhydride is small, the reaction is not sufficiently carried out, and if too much, it is difficult to be completely removed after completion of the reaction. The basic catalyst may, for example, be pyridine, triethylamine, trimethylamine, tributylamine or trioctylamine, and the pyridine is preferred because it has a moderate basicity for allowing the reaction to proceed. Further, examples of the acid anhydride include acetic anhydride, trimellitic anhydride, and pyromellitic acid. Among them, acetic anhydride is used, and purification after completion of the reaction is preferred. The organic solvent is not particularly limited as long as it is a polyamic acid, and specific examples thereof include hydrazine, Ν'-dimethylformamide, hydrazine, Ν'_dimethylglyoxime, Ν-methyl-2-pyrrolidone, Ν-methyl caprolactam, dimethyl hydrazine, tetramethyl urea, dimethyl hydrazine, hexamethyl sulfoxide, decyl-butyrolactone, and the like. The imidization ratio of the imidization of the oxime by the catalyst is controlled by adjusting the amount of the catalyst, the reaction temperature, and the reaction time. The produced polyimine is obtained by recovering a precipitate formed by putting the above reaction solution into a weak solvent. In this case, the weak solvent to be used is not particularly limited, and examples thereof include methanol, acetone, hexane, butyl cellosolve, heptane, methyl ethyl ketone, methyl isobutyl ketone, ethanol, toluene, and benzene. , water, etc. The polyimine precipitated after being injected into a weak solvent, after being filtered, can be made into a powder under normal pressure or reduced pressure at room temperature or by heating, and the polyimine powder is redissolved in an organic solvent. The step of precipitating is repeated 2 to 10 times to purify the polyimine. This purification step is preferred when the primary precipitation recovery operation does not remove impurities. The molecular weight of the specific polyimine used in the present invention is not particularly limited, but from the viewpoints of ease of handling and stability of properties at the time of film formation, -25-200841093, the weight average molecular weight is 2,000 to 200,000. Better, better for 4,00 0~5 0,000. The molecular weight is calculated by GPC (gel permeation chromatography). < (B) Component: Specific Crosslinkable Compound> The liquid crystal alignment treatment agent of the present invention contains at least two oxetines represented by the following formula [1] in addition to the above polymer component. The crosslinkable compound (B) having at least two oxetanyl groups represented by the following formula [1] in the molecule of the crosslinkable compound (B) of the alkyl group (hereinafter referred to as a specific crosslinkable compound) Μ 匕 15 ]

[1] 氧雜環丁烷基,已知與羧基或羥基在熱或酸觸媒的存 在下反應,所以,特定交聯性化合物與聚醯胺酸或聚醯亞 胺中所含的羧基或羥基反應,而成爲在聚合物間交聯的膜 。而且,氧雜環丁烷基,除了與羧基或羥基的反應以外, 亦引起自聚合反應,特別是氧雜環丁院基,因爲親核性高 於環氧,故可得到最終轉換率高、且聚合度高的聚合物。 亦即,使用本發明的液晶配向處理劑而得到的液晶配向膜 ,藉由聚合物間的交聯及氧雜環丁烷基的自聚合所生成的 聚合物而成爲耐熱性高的膜。 -26- 200841093 此外,因爲氧雜環丁烷基爲4員環結構,與羧基或羥 基反應時及自聚合時,與3員結構之環氧比較下,鍵結部 位上多含一個伸甲基。因此,由本發明的液晶配向處理劑 所得到的膜,與使用環氧系交聯性化合物的膜比較下,因 爲成爲拉伸或靭性高者,故藉由硏磨之聚合物的延伸性不 易受到阻礙。 所以,由本發明的液晶配向處理劑所得到的液晶配向 膜,與不含有交聯性化合物之液晶配向膜或含有環氧系交 聯性化合物之液晶配向膜比較,傾斜角對於熱的安定性提 高,而且,對於弱的硏磨條件之液晶的配向性亦未降低。 本發明的液晶配向處理劑中,特定交聯性化合物所具 有的氧雜環丁烷基,只要爲2個以上者即可,並沒有特別 的限定,較佳爲2〜50個,更佳爲2〜20個。 此外,特定交聯性化合物的具體結構並沒有特別的限 定,但可列舉例如下述式[2]所表示的化合物。[1] Oxetane, which is known to react with a carboxyl group or a hydroxyl group in the presence of a heat or an acid catalyst, and therefore, a specific crosslinkable compound and a carboxyl group contained in polyglycine or polyimine or The hydroxyl group reacts to form a film that crosslinks between the polymers. Further, the oxetane group, in addition to the reaction with a carboxyl group or a hydroxyl group, also causes a self-polymerization reaction, particularly an oxetane group, since the nucleophilicity is higher than that of the epoxy group, the final conversion ratio can be high. And a polymer with a high degree of polymerization. In other words, the liquid crystal alignment film obtained by using the liquid crystal alignment agent of the present invention is a film having high heat resistance by crosslinking between polymers and polymerization of a oxetane group. -26- 200841093 In addition, because the oxetane group is a 4-membered ring structure, when reacting with a carboxyl group or a hydroxyl group and self-polymerizing, the bonding site contains a methyl group in comparison with the epoxy resin of the 3-member structure. . Therefore, the film obtained by the liquid crystal alignment treatment agent of the present invention is less likely to be stretched or toughened than the film using the epoxy-based crosslinkable compound, so that the elongation of the polymer by honing is less susceptible. Obstruction. Therefore, the liquid crystal alignment film obtained by the liquid crystal alignment treatment agent of the present invention has improved tilt stability with respect to heat compared with a liquid crystal alignment film containing no crosslinkable compound or a liquid crystal alignment film containing an epoxy crosslinkable compound. Moreover, the alignment of the liquid crystal for weak honing conditions is not lowered. In the liquid crystal alignment agent of the present invention, the oxetane group which the specific crosslinkable compound has is not particularly limited as long as it is two or more, and is preferably 2 to 50, more preferably 2 to 20 pieces. Further, the specific structure of the specific crosslinkable compound is not particularly limited, and examples thereof include a compound represented by the following formula [2].

式[2]中,X!表示 N、NH、C0、0、S、S02、Si、倍 半矽氧烷、聚矽氧烷、或碳數1〜20的有機基,此有機基 中亦可含有雜原子(N、0、S、Si),而且,Χι的碳數 1〜20的有機基中,可爲含有具有環狀結構之有機基。具體 -27· 200841093 而言,係環丙烷環、環丁烷環、環戊烷環、環己烷環、環 庚烷環、環辛烷環、環壬烷環、環癸烷環、環十一烷環、 環十二烷環、環十三烷環、環十四烷環、環十五烷環、環 十六烷環、環十七烷環、環十八烷環、環十九烷環、環二 十烷環、三環二十烷環、三環二十二烷環、雙環庚烷環、 十氫萘環、降冰片烯環、金剛烷環、苯環、萘環、四氫萘 環、葜環、茚環、芴環、蒽環、菲環、1,8-苯嵌萘、吡咯 環、咪唑環、噁唑環、噻唑環、吡唑環、吡啶環、嘧啶環 、喹啉環、吡唑啉環、異喹啉環、味唑環、嘌呤環、噻二 唑環、噠嗪環、三嗪環、吡唑烷環、三唑環、吡嗪環、苯 並唑唑環、苯並咪唑環、間二氮茚環、檸檬素環、菲繞啉 環、吲哚環、喹喔啉環、苯並噻唑環、吩噻嗪環、噁二唑 環、吖啶環、噁唑環、哌嗪環、哌啶環、二噁烷環、嗎啉 環、吖庚因環、二吖庚因環、萘錠環、吩嗪環、酞嗪環等 。X2及X3各自獨立地表示單鍵、NH、CO、〇、s、S02、 或碳數1〜20的有機基,此有機基中亦可含有雜原子(N、 0、S、Si )。 丫!及Y2各自獨立地表示碳數1〜20,較佳爲1〜15的 有機基,此有機基中亦可含有雜原子(N、0、S、Si )。 m、η各自獨立地表示0〜2 0的整數,較佳爲〇〜15的 整數,而且m + n爲2〜20的整數,較佳爲2〜15的整數。 式[2]中所表示的特定交聯性化合物中,較佳者係Xl 表示N、NH、CO、Ο、倍半矽氧烷、聚矽氧烷、或碳數 1〜10的有機基,此有機基中亦可含有雜原子(N、〇), -28- 200841093 而且,X!的碳數1〜10的有機基中,亦包括具有環己垸環 、苯環、萘環、芴環、吡咯環、咪唑環、吡唑環、吡啶環 、嘧啶環、咔唑環、噠嗪環、三嗪環、三唑環、吡嗪環、 苯並咪哩環、或喹喔啉環的環狀結構;而且,X2及X3各 自獨立地爲 NH、CO、COO、OCO、0、CONH、或 NHCO ;Υι及Y2各自獨立地表不碳數1〜10的院基;m、η各自 獨立地表示〇〜20的整數,且m + n爲2〜20的整數。 式[2]中’ X!爲倍半矽氧烷時,其例子可列舉選自一 般式[S1]〜[S4]的結構。 -29- 200841093In the formula [2], X! represents N, NH, C0, 0, S, S02, Si, sesquiterpene oxide, polyoxane, or an organic group having 1 to 20 carbon atoms. The organic group having a hetero atom (N, 0, S, Si) and having a carbon number of 1 to 20 may be an organic group having a cyclic structure. Specific -27·200841093, a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a cyclohexane ring, a cycloheptane ring, a cyclooctane ring, a cyclodecane ring, a cyclodecane ring, a ring Monoalkane, cyclododecane ring, cyclotridecane ring, cyclotetradecane ring, cyclopentadecane ring, cyclohexadecane ring, cycloheptadecane ring, cyclooctadecane ring, cyclopentadecane Ring, cycloecosane ring, tricyclohexadecane ring, tricyclotetracosane ring, bicycloheptane ring, decahydronaphthalene ring, norbornene ring, adamantane ring, benzene ring, naphthalene ring, tetrahydrogen Naphthalene ring, anthracene ring, anthracene ring, anthracene ring, anthracene ring, phenanthrene ring, 1,8-benzoin, pyrrole ring, imidazole ring, oxazole ring, thiazole ring, pyrazole ring, pyridine ring, pyrimidine ring, quin Physic ring, pyrazoline ring, isoquinoline ring, oxazole ring, anthracene ring, thiadiazole ring, pyridazine ring, triazine ring, pyrazolidine ring, triazole ring, pyrazine ring, benzoxazole Ring, benzimidazole ring, m-diazepine ring, limonin ring, phenanthroline ring, anthracene ring, quinoxaline ring, benzothiazole ring, phenothiazine ring, oxadiazole ring, acridine ring, Oxazole ring, piperazine ring, piperidine ring, dioxane , Morpholine ring, azepine ring, diazepine ring, a naphthalene ring spindles, phenazine ring, a phthalazine ring. X2 and X3 each independently represent a single bond, NH, CO, hydrazine, s, S02, or an organic group having 1 to 20 carbon atoms, and the organic group may also contain a hetero atom (N, 0, S, Si). Hey! And Y2 each independently represent an organic group having 1 to 20 carbon atoms, preferably 1 to 15 carbon atoms, and the organic group may further contain a hetero atom (N, 0, S, Si). m and η each independently represent an integer of 0 to 20, preferably an integer of 〇 15 , and m + n is an integer of 2 to 20, preferably an integer of 2 to 15. Among the specific crosslinkable compounds represented by the formula [2], preferred is that X1 represents N, NH, CO, hydrazine, sesquioxane, polyoxyalkylene or an organic group having 1 to 10 carbon atoms. The organic group may also contain a hetero atom (N, 〇), -28- 200841093. Further, the organic group having a carbon number of 1 to 10 of X! also includes a cyclohexanyl ring, a benzene ring, a naphthalene ring, and an anthracene ring. a ring of a pyrrole ring, an imidazole ring, a pyrazole ring, a pyridine ring, a pyrimidine ring, a carbazole ring, a pyridazine ring, a triazine ring, a triazole ring, a pyrazine ring, a benzoxanthene ring, or a quinoxaline ring. Further, X2 and X3 are each independently NH, CO, COO, OCO, 0, CONH, or NHCO; Υι and Y2 each independently represent a yard having a carbon number of 1 to 10; m and η are each independently represented An integer of 〇~20, and m + n is an integer of 2 to 20. When 'X! is a sesquioxane in the formula [2], examples thereof include a structure selected from the general formulas [S1] to [S4]. -29- 200841093

<.>< ^ [S2] .Si、 [S3]<.>< ^ [S2] .Si, [S3]

i-O- [S4] 仰· ^Si-O—Si^° 式[2]中,X2爲聚矽氧烷時,此聚矽氧烷的例子可列 -30- 200841093 舉具有由一般式[PI]、[P2]、[P3]及[P4]所成的群所選出的 至少1種的結構之聚矽氧烷。 [化 18]iO- [S4] ̄··Si-O—Si^° In the formula [2], when X2 is a polyoxyalkylene, an example of the polyoxyalkylene can be listed as -30-200841093 by the general formula [PI] And at least one structure selected from the group consisting of [P2], [P3], and [P4]. [Chem. 18]

Si一Ο- [Ρ 1]Si Ο - [Ρ 1]

CP2]CP2]

[P4] 式[P1]〜[P4]中之1^、112、1^、1^4、尺5各自獨立地爲 由氫原子、羥基、碳數1〜1 〇的烷基、烷氧基、脂肪族環 基、或芳香族環基所選出之基。 式[2]的較佳具體例子,可列舉下述式[3]〜[8]的結構 [化 19][1], 112, 1^, 1^4, and 5 in the formulas [P1] to [P4] are each independently an alkyl group, an alkoxy group having a hydrogen atom, a hydroxyl group, and a carbon number of 1 to 1 fluorene. A selected group of an aliphatic cyclic group or an aromatic ring group. Preferred specific examples of the formula [2] include the structures of the following formulas [3] to [8] [Chem. 19]

[3] 式[3]中,X2及X3各自獨立地表示單鍵、NH、CO、〇 、S、S02、或碳數1〜20的有機基,此有機基中亦可含有 雜原子(N'O、S、Si) ; Yi及Y2各自獨立地表示碳數 -31 - 200841093 1〜20,較佳爲碳數1〜15的有機基,此有機基中亦可含有 雜原子(N、Ο、S、Si ) ; Ζι 表示單鍵、NH、N ( CH3 ) 、NHCO、CONH、NHCONH、CO、COO、Ο、S、S02、 CF2、C ( CF3) 2、Si ( CH3) 2、OSi ( CH3) 2、Si(CH3)2〇 、OSi(CH3) 20、或碳數1〜10的烷基;m、n各自獨立地 表示0〜5的整數,較佳爲0〜3的整數,且m + n表示2〜10 的整數,較佳爲2〜6的整數。 式[3]所表示的特定交聯性化合物中,較佳係X2及X3 各自獨立地表示 NH、CO、COO、OCO、Ο、CONH、或 NHCO; Ζ!表示單鍵、CH2、C(CH3) 2、NH、N(CH3) 、NHCO、CONH、CO、COO、O、S02、C ( CF3 ) i、 Si(CH3)2、OSi ( CH3 ) 2、Si ( CH3) 20、OSi ( CH3) 20、 或碳數1〜5的烷基;Y1及Y2各自獨立地爲碳數1〜10的 烷基;m、η各自獨立地表示0〜5的整數,較佳爲0〜3的 整數,且m + n表示2〜10的整數,較佳爲2〜6的整數。 [化 20][3] In the formula [3], X2 and X3 each independently represent a single bond, NH, CO, hydrazine, S, S02, or an organic group having 1 to 20 carbon atoms, and the organic group may further contain a hetero atom (N). 'O, S, Si); Yi and Y2 each independently represent a carbon number of -31 - 200841093 1 to 20, preferably an organic group having a carbon number of 1 to 15, which may also contain a hetero atom (N, Ο) , S, Si); Ζι means single bond, NH, N (CH3), NHCO, CONH, NHCONH, CO, COO, Ο, S, S02, CF2, C (CF3) 2, Si (CH3) 2, OSi ( CH3) 2, Si(CH3)2〇, OSi(CH3)20, or an alkyl group having 1 to 10 carbon atoms; m and n each independently represent an integer of 0 to 5, preferably an integer of 0 to 3, and m + n represents an integer of 2 to 10, preferably an integer of 2 to 6. Among the specific crosslinkable compounds represented by the formula [3], preferred ones X2 and X3 each independently represent NH, CO, COO, OCO, hydrazine, CONH, or NHCO; Ζ! represents a single bond, CH2, C (CH3) 2, NH, N (CH3), NHCO, CONH, CO, COO, O, S02, C (CF3) i, Si (CH3) 2, OSi (CH3) 2, Si (CH3) 20, OSi (CH3) 20, or an alkyl group having 1 to 5 carbon atoms; Y1 and Y2 are each independently an alkyl group having 1 to 10 carbon atoms; and m and η each independently represent an integer of 0 to 5, preferably an integer of 0 to 3, Further, m + n represents an integer of 2 to 10, preferably an integer of 2 to 6. [Chem. 20]

式[4]中,X!表示 NH、N(CH3) 、NHCO、CONH、 NHCONH、CO、COO、OCO、Ο、S、S02、CF2、C(CF3)2 、Si ( ch3 ) 2、OSi ( CH3 ) 2、Si ( ch3 ) 2〇、或 OSi(CH3)2〇 ; Yi及Y2各自獨立地表示碳數1〜10的烷基, 較佳爲碳數1〜5的院基。 -32- 200841093 式[4 ]所表示的特定交聯性化合物中,較佳者係χ 1爲 NH、N ( CH3 ) 、NHCO、CONH、CO、COO、〇c〇、〇、 S02、C ( CF3) 2、Si ( CH3 ) 2、〇Si ( CH3 ) 2、Si(CH3)2〇 、或〇8丨(0:113)2〇;丫1及Y2各自獨立地表示碳數i〜i〇 的烷基。In the formula [4], X! represents NH, N(CH3), NHCO, CONH, NHCONH, CO, COO, OCO, Ο, S, S02, CF2, C(CF3)2, Si(ch3) 2, OSi ( CH3) 2, Si(ch3) 2〇, or OSi(CH3)2〇; Yi and Y2 each independently represent an alkyl group having 1 to 10 carbon atoms, preferably a group having 1 to 5 carbon atoms. -32- 200841093 Among the specific crosslinkable compounds represented by the formula [4], preferred ones are NH, N(CH3), NHCO, CONH, CO, COO, 〇c〇, 〇, S02, C ( CF3) 2, Si (CH3) 2, 〇Si (CH3) 2, Si(CH3)2〇, or 〇8丨(0:113)2〇; 丫1 and Y2 each independently represent the carbon number i~i〇 Alkyl.

式[5]中,又1爲N、碳數1〜2〇的脂肪族環、碳數1〜2〇 的芳香族環或碳數1〜20的伸烷基,較佳爲N、碳數1〜15 的脂肪族環、碳數1〜15的芳香族環或碳數1〜15的伸烷基 ,更佳係Χι爲N、碳數1〜10的脂肪族環、碳數1〜1〇的 芳香族環或碳數1〜10的伸烷基。 式[5]中的Υι及Y2各自獨立地爲碳數1〜10的烷基’ 較佳係各自爲碳數1〜5的烷基。 式[5]中,m、η表示〇〜20的整數,且m + n表示2〜20 的整數;較佳係m、η表示0〜15的整數,且m + n表示 2〜15的整數;更佳係m、η表示〇〜10的整數,且m + n表 示2〜10的整數。 因此,Xi、Yi、Y2、m、η的較佳組合,如下述。 式[5]中的Χι爲Ν、碳數1〜20的脂肪族環、碳數 1〜2 0的芳香族環或碳數1〜20的伸烷基;丫1及Y2各自爲 -33-In the formula [5], 1 is N, an aliphatic ring having 1 to 2 carbon atoms, an aromatic ring having 1 to 2 carbon atoms, or an alkylene group having 1 to 20 carbon atoms, preferably N and carbon number. 1 to 15 of an aliphatic ring, an aromatic ring having 1 to 15 carbon atoms or an alkylene group having 1 to 15 carbon atoms, more preferably an aliphatic ring having N, a carbon number of 1 to 10, and a carbon number of 1 to 1. An aromatic ring of hydrazine or an alkylene group having a carbon number of 1 to 10. Υι and Y2 in the formula [5] are each independently an alkyl group having 1 to 10 carbon atoms, and each of them is preferably an alkyl group having 1 to 5 carbon atoms. In the formula [5], m and η represent an integer of 〇-20, and m + n represents an integer of 2 to 20; preferably, m and η represent an integer of 0 to 15, and m + n represents an integer of 2 to 15. More preferably, m and η represent an integer of 〇10, and m + n represents an integer of 2 to 10. Therefore, a preferred combination of Xi, Yi, Y2, m, η is as follows. In the formula [5], Χ is Ν, an aliphatic ring having 1 to 20 carbon atoms, an aromatic ring having 1 to 20 carbon atoms or an alkylene group having 1 to 20 carbon atoms; and 丫1 and Y2 are each -33-

200841093 碳數1〜10的烷基;m、η爲0〜20的整數,且m + n爲 的整數。 較佳係Xi爲N、碳數1〜15的脂肪族環、碳數 的芳香族環或碳數1〜15的伸烷基;Y!及Y2各自爲 1〜5的烷基;m、η爲0〜15的整數,且m + n爲2〜15 數。 更佳係乂1爲N、碳數1〜10的脂肪族環、碳數 的芳香族環或碳數1〜10的伸烷基;Yi及Y2各自爲 1〜5的烷基;m、η爲0〜10的整數,且m + n爲2〜10 數。 上述Xi中,碳數1〜20的脂肪族環、碳數1〜20 香族環的具體例子列舉如下。 脂肪族環,可列舉環丙烷環、環丁烷環、環戊娱 環己院環、環庚院環、環辛院環、環壬院環、環癸煩 環十一院環、環十二院環、環十三院環、環十四院釋 十五烷環、環十六烷環、環十七烷環、環十八院環、 九烷環、環二十烷環、三環二十烷環、三環二十二娱 雙環庚院環、降冰片烯環、金剛院環。 芳香族環,可列舉十氫萘環、苯環、萘環、四 、葜環、茚環、芴環、蒽環、菲環、1,8-苯嵌萘、 、咪唑環、噁唑環、噻唑環、吡唑環、吡啶環、喷 嗤琳環、卩比哩琳環、異睦琳環、昨哩環、嘿U令環 環、噠嗪環、三嗪環、吡唑烷環、三唑環、_嗓環 哩嗤環、苯並咪唑環、間二氮茚環 '檸檬素環、菲 2〜20 1〜1 5 碳數 的整 1〜10 碳數 的整 的芳 環、 環、 、環 環十 環、 萘環 咯環 環、 二唑 苯並 啉環 -34- 200841093 、吲哚環、喹喔啉環、苯並噻哗環、吩噻曉環、11惡二嗤環 、吖啶環、噁唑環、哌嗪環、哌啶環、二11惡院環、嗎琳環 、吖庚因環、二吖庚因環、萘锭環、吩嗪環、献曉環等。 此等中,較佳爲環丙烷環、環己烷環、降冰片嫌環、 金剛烷環、苯環、萘環、四氫萘環、芴環、蒽環、卩比略環 、咪唑環、噁唑環、噻唑環、吡唑環、吡啶環、嘧啶環、 喹啉環、吡唑啉環、咔唑環、噠嗪環、三嗪環、三唑環、 吡嗪環、苯並咪唑環、哌嗪環、哌啶環。更佳爲環己烷環 、降冰片烯環、金剛烷環、苯環、萘環、四氫萘環、吡咯 環、咪唑環、吡啶環、嘧啶環、咔唑環、噠嗪環、三曉環 、三唑環、吡嗪環、苯並咪唑環、哌嗪環、哌啶環。 [化2¾200841093 An alkyl group having 1 to 10 carbon atoms; m and η are integers of 0 to 20, and m + n is an integer. Preferably, Xi is N, an aliphatic ring having 1 to 15 carbon atoms, an aromatic ring having a carbon number or an alkylene group having 1 to 15 carbon atoms; each of Y and Y2 is an alkyl group having 1 to 5; m, η It is an integer from 0 to 15, and m + n is a number from 2 to 15. More preferably, the oxime 1 is N, an aliphatic ring having 1 to 10 carbon atoms, an aromatic ring having a carbon number or an alkylene group having 1 to 10 carbon atoms; each of Yi and Y2 is an alkyl group having 1 to 5; m, η It is an integer of 0 to 10, and m + n is a number of 2 to 10. Specific examples of the aliphatic ring having 1 to 20 carbon atoms and the aromatic ring having 1 to 20 carbon atoms in the above Xi are as follows. The aliphatic ring may, for example, be a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a ring, a ring, a ring, a ring, a ring, a ring, a ring, a ring, and a ring. Courtyard ring, ring 13 courtyard ring, ring 14 courtyard discharge pentadecane ring, cyclohexadecane ring, cycloheptadecane ring, ring 18 ring ring, pentane ring Decane ring, three ring twenty two entertainment double ring Gengyuan ring, norbornene ring, diamond ring. Examples of the aromatic ring include a decahydronaphthalene ring, a benzene ring, a naphthalene ring, a tetra, an anthracene ring, an anthracene ring, an anthracene ring, an anthracene ring, a phenanthrene ring, a 1,8-benzoin naphthalene, an imidazole ring, an oxazole ring, Thiazole ring, pyrazole ring, pyridine ring, spurring ring, 卩 哩 哩 ring, 睦 睦 ring, 哩 ring, 嘿 U ring ring, azine ring, triazine ring, pyrazol ring, three Oxazole ring, 嗓 ring oxime ring, benzimidazole ring, m-diazepine ring 'limon ring, phenanthrene 2~20 1~1 5 carbon number of whole 1~10 carbon number of whole aromatic ring, ring, , cyclopentacyclic, naphthalene ring, oxadiazole benzoxanyl-34-200841093, anthracene ring, quinoxaline ring, benzothiazepine ring, phenothiazine ring, 11 oxadiazine ring, hydrazine A pyridine ring, an oxazole ring, a piperazine ring, a piperidine ring, a dioxane ring, a morphine ring, a hydrazine ring, a dioxin ring, a naphthalene ring, a phenazine ring, a tribute ring, and the like. Among these, preferred are a cyclopropane ring, a cyclohexane ring, a norbornane ring, an adamantane ring, a benzene ring, a naphthalene ring, a tetrahydronaphthalene ring, an anthracene ring, an anthracene ring, an anthracene ring, an imidazole ring, Oxazole ring, thiazole ring, pyrazole ring, pyridine ring, pyrimidine ring, quinoline ring, pyrazoline ring, indazole ring, pyridazine ring, triazine ring, triazole ring, pyrazine ring, benzimidazole ring , piperazine ring, piperidine ring. More preferably, it is a cyclohexane ring, a norbornene ring, an adamantane ring, a benzene ring, a naphthalene ring, a tetrahydronaphthalene ring, a pyrrole ring, an imidazole ring, a pyridine ring, a pyrimidine ring, an indazole ring, a pyridazine ring, or a trioxane. Ring, triazole ring, pyrazine ring, benzimidazole ring, piperazine ring, piperidine ring. [化23⁄4

式[6]中,Υι及Υ2各自獨立地表示碳數1〜10的烷基 ,較佳爲碳數1〜5的烷基,η表示1〜10的整數,較佳爲 1〜5的整數。 [化 23]In the formula [6], Υι and Υ2 each independently represent an alkyl group having 1 to 10 carbon atoms, preferably an alkyl group having 1 to 5 carbon atoms, and η represents an integer of 1 to 10, preferably an integer of 1 to 5. . [Chem. 23]

式[7]中,Υ!及Υ2各自獨立地表示碳數1〜1〇的院基 較佳爲碳數1〜5的烷基,η表示1〜10的整數,較佳爲 -35- 200841093 1〜5的整數。 [化 24]In the formula [7], Υ! and Υ2 each independently represent a carbon number of 1 to 1 Å, preferably a carbon number of 1 to 5, and η represents an integer of 1 to 10, preferably -35 to 200841093. An integer from 1 to 5. [Chem. 24]

[8] 式[8]中,Y2各自獨立地表示碳數1〜10的烷基 ,較佳爲碳數1〜5的烷基,η表示1〜10的整數,較佳爲 1〜5的整數。 更具體的特定交聯性化合物,可列舉式[9]〜[19]的化 合物。 -36- 200841093 msi[8] In the formula [8], Y2 each independently represents an alkyl group having 1 to 10 carbon atoms, preferably an alkyl group having 1 to 5 carbon atoms, and η represents an integer of 1 to 10, preferably 1 to 5 Integer. More specific specific crosslinkable compounds include the compounds of the formulae [9] to [19]. -36- 200841093 msi

[11][11]

[13][13]

-37- 200841093 [化 26]-37- 200841093 [Chem. 26]

-38- 200841093-38- 200841093

上述化合物爲特定交聯性化合物的一例,並 此寺’此外’本發明的液晶配向處理劑中所含有 聯性化合物,可爲1種,亦可爲組合2種以上。 (液晶配向處理劑) 本發明的液晶配向處理劑中,(B )成份( 性化合物)的含量,相對於由聚醯胺酸及/或聚 成的(A)成份(聚合物成份)100質量份,爲〇 量份較佳,爲了進行交聯反應而表現出所望的膜 且不使液晶的配向性降低,更佳爲〇 · 1〜1 〇 〇質量 佳爲1〜50質量份。 本發明的液晶配向處理劑並沒有特別的限制 39- 非限定於 的特定交 特定交聯 酸亞胺所 • 1〜150質 硬化性, 份,特別 ,但通常 200841093 在製作液晶配向膜時,因爲必須在基板上形成0·01〜1 ·〇 # m的均勻的薄膜,故以除了含有(A )成份、(B )成份之 外,再含有使此等成份溶解之有機溶劑之塗佈液爲較佳。 本發明的液晶配向處理劑含有上述有機溶劑時,由藉塗佈 形成均勻的薄膜之觀點而言,有機溶劑的含量’在液晶配 向處理劑中爲90〜99質量%較佳,92〜97質量%更佳。另一 方面,(Α)成份的含量,較佳爲0.4〜9.9質量% ’特別佳 爲0.5〜9.9質量%,( Β )成份的含量較佳爲〇·1〜9.6質量 %,特別佳爲〇 . 1〜9 · 5質量%。此等的含量,可依目標的液 晶配向膜的膜厚而適當地變更。 本發明的液晶配向處理劑中所含有的有機溶劑的具體 例子,可列舉上述聚醯胺酸的合成反應中所使用的有機溶 劑。特別佳爲Ν,Ν-二甲基甲醯胺、Ν,Ν-二甲基乙醯胺、 Ν-甲基-2-耻咯烷酮、二甲基亞颯、丁內酯,此等的有 機溶劑可使用1種,亦可倂用2種以上。 此外,有機溶劑中,爲了提高塗膜的均勻性之目的, 較佳係含有乙基溶纖劑、丁基溶纖劑、乙基卡必醇、丁基 卡必醇、二乙二醇二乙醚、二乙二醇單乙醚、二乙二醇單 丁醚、乙基卡必醇乙酸酯、乙二醇、乙二醇單己醚、^甲 氧基· 2 -丙醇、卜乙氧基-2 -丙醇、1 _ 丁氧基-2 -丙醇、1 -苯 氧基-2-丙醇、丙二醇單乙酸酯、丙二醇二乙酸酯、丙二 醇-1-單甲醚-2_乙酸酯、丙二醇-1-單乙醚-2-乙酸酯、二丙 二醇、二丙二醇單甲醚、二丙二醇單乙醚、4 -羥基-4·甲 基-2·戊酮、2- (2 -乙氧基丙氧基)丙醇、乳酸甲酯、乳酸 -40、 200841093 乙酯、乳酸η-丙酯、乳酸η-丁酯、乳酸異戊酯等具有低表 面張力之溶劑;此等溶劑通常可使用1種或混合2種以上 使用。此等溶劑一般而言因爲使聚醯胺酸或聚醯亞胺溶解 的能力低,故爲有機溶劑中的80質量%下較佳,更佳爲 60質量%以下。此外,若希望提高塗膜的均勻性,爲有機 溶劑中的5質量%以上較佳,更佳爲20質量%以上。 本發明的液晶配向處理劑,除了( A )成份、(Β )成 份、及上述有機溶劑以外,在不損及本發明的效果的範圍 內,亦可含有添加劑成份。作爲添加劑成份,可列舉用於 提高液晶配向膜與基板的密著性之化合物、用於提高塗膜 的平坦化性之界面活性劑等。 提高塗膜與基板的密著性之化合物的具體例子,可列 舉下述所表示者。例如3-胺基丙基三甲氧基矽烷、3-胺基 丙基三乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙 基三乙氧基矽烷、N- (2-胺基乙基)-3-胺基丙基三甲氧基 矽烷、N- ( 2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、 3 -脈基丙基二甲氧基砂院、3 -脈基丙基二乙氧基砂院、N· 乙氧基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基- 3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基丙基三乙撐三 胺、N-三甲氧基矽烷基丙基三乙撐三胺、10-三甲氧基矽 烷基-1,4,7-三氮雜癸烷、ίο-三乙氧基矽烷基-1,4,7-三氮雜 癸烷、9-三甲氧基矽烷基-3,6-二氮雜壬基乙酸酯、9-三乙 氧基砍院基-3,6 -二氮雜壬基乙酸酯、N -节基-3-胺基丙基 三甲氧基矽烷、N-苄基-3-胺基丙基三乙氧基矽烷、N-苯 -41 - 200841093 基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙基三乙氧 基矽烷、N-雙(氧化乙撐)-3-胺基丙基三甲氧基矽烷、 N-雙(氧化乙撐)-3-胺基丙基三乙氧基矽烷等之含官能 性矽烷之化合物。 添加此寺化合物時’可得到密者性提筒的效果,由不 使液晶的配向性降低之觀點而言,相對於(A )成份1〇〇 質量份爲〇·1〜30質量份較佳,更佳爲1〜20質量份,特別 佳爲1〜10質量份。 用於提高塗膜的平坦性之界面活性劑,可列舉氟系界 面活性劑、聚矽氧系界面活性劑、非離子系界面活性劑等 。更具體而言,可列舉例如F-TOP EF301、EF3 03、EF352 (以上,TOHKEM PRODUCT 公司製)、MEGAFAC F171 、F173、R-30 (以上,大曰本油墨公司製)、FULORD FC430、F431 (以上,住友 3M 公司製)、AsahiGuard AG710、Surf Ion S-382、SC101、SC102、SC103、SC104 、SC105、SC106(以上,旭硝子公司製)等。此等的界 面活性劑的使用比例,相對於聚合物成份1 0 0質量份,較 佳爲0.0 1〜2質量份,更佳爲0.01〜1質量份。 <液晶配向膜-液晶顯示元件> 本發明的液晶配向處理劑,可塗佈於基板上、燒成後 ,以硏磨處理或光照射等進行配向處理,或在垂直配向用 途等無進行配向處理,作爲液晶配向膜使用。 此時,所使用的基板只要是透明性高的基板即可,並 -42- 200841093 沒有特別的限制,可使用玻璃基板、丙烯基基板或聚碳酸 酯基板等之塑膠基板等。而且,使用形成有用於液晶驅動 的ITO電極等之基板,由製程的簡單化的觀點而言較佳; 此外,反射型的液晶顯示元件,若僅單側的基板,可使用 矽晶圓等不透明物,此時的電極亦可使用反射鋁等的光之 材料。 液晶配向處理劑的塗佈方法並沒有特別的限制,但在 工業上一般爲以網版印刷、膠版印刷、柔版印刷、噴墨等 進行之方法。其他的塗佈方法,爲浸漬、輥塗機、狹縫式 塗佈機、旋轉塗佈機等,可依目的使用。 塗佈液晶配向處理劑後的燒成,可用100〜3 50 °c的任 意溫度進行,但較佳爲120〜300°C,更佳爲150〜250 °C。 此燒成可於加熱板、熱風循環爐、紅外線爐等進行。 燒成後的塗膜的厚度,因爲太厚則變得不利於液晶顯 示元件的消耗電力方面,太薄則會有液晶顯示元件的信賴 性降低的情況,故較佳爲 5〜3 00nm,更佳爲 10〜100nm。 使液晶進行水平配向或傾斜配向時,以硏磨或偏光紫外線 照射等進行處理。 本發明的液晶顯示元件,藉由上述手法由本發明的液 晶配向處理劑得到附有液晶配向膜之基板後,用習知的方 法製作液晶盒,製成液晶顯示元件者。 若列舉液晶盒製作之一例,可列舉準備已形成液晶配 向膜之1對基板,於其中一個的基板的液晶配向膜上散佈 隔板,在使液晶配向膜朝向內側下,貼合另一個的基板, -43- 200841093 減壓注入液晶後封閉之方法;或者,在散佈了隔板之液晶 配向膜面上滴入液晶後,貼合基板後進行封閉之方法等。 此時的隔板厚度,較佳爲1〜30以m,更佳爲2〜10 # m。 如此作法,使用本發明的液晶配向處理劑所製作@、液 晶顯示元件,可製成傾斜角的安定性優異的液晶顯示^ β ,適合於ΤΝ元件、STN元件、TFT液晶元件,更適合於 垂直配向型的液晶顯示元件等。 【實施方式】 以下列舉實施例’更詳細地說明本發明,但並不限定 於此等實施例。 本實施例所使用的化合物的略號如下述。 (四羧酸二酐)The above-mentioned compound is an example of a specific cross-linking compound, and the compound to be used in the liquid crystal alignment agent of the present invention may be one type or a combination of two or more types. (Liquid Crystal Alignment Treatment Agent) The content of the (B) component (sex compound) in the liquid crystal alignment treatment agent of the present invention is 100% by mass based on the poly (amic acid) and/or the (A) component (polymer component). The portion is preferably a ruthenium component, and the film is formed to exhibit a crosslinking reaction, and the alignment property of the liquid crystal is not lowered. More preferably, the film is preferably 1 to 50 parts by mass. The liquid crystal alignment treatment agent of the present invention is not particularly limited. 39- Non-limiting specific cross-linking acid imine. 1~150 hardenability, part, special, but usually 200841093 in the production of liquid crystal alignment film, because A uniform film of 0·01 〜1·〇# m must be formed on the substrate, so that the coating liquid containing the organic solvent in which the components are dissolved in addition to the components (A) and (B) is Preferably. When the liquid crystal alignment agent of the present invention contains the above organic solvent, the content of the organic solvent is preferably from 90 to 99% by mass in the liquid crystal alignment treatment agent from the viewpoint of forming a uniform film by coating, and is preferably 92 to 97% by mass. % is better. On the other hand, the content of the (Α) component is preferably from 0.4 to 9.9% by mass 'particularly preferably from 0.5 to 9.9% by mass, and the content of the (Β) component is preferably from 〜1 to 9.6% by mass, particularly preferably 〇 . 1~9 · 5 mass%. The content of these can be appropriately changed depending on the film thickness of the target liquid crystal alignment film. Specific examples of the organic solvent contained in the liquid crystal alignment agent of the present invention include organic solvents used in the synthesis reaction of the above polyamic acid. Particularly preferred are hydrazine, hydrazine-dimethylformamide, hydrazine, hydrazine-dimethylacetamide, hydrazine-methyl-2-pyrrolidone, dimethyl hydrazine, butyrolactone, etc. One type of the organic solvent may be used, or two or more types may be used. Further, in the organic solvent, in order to improve the uniformity of the coating film, ethyl cellosolve, butyl cellosolve, ethyl carbitol, butyl carbitol, diethylene glycol diethyl ether, and the like are preferably contained. Ethylene glycol monoethyl ether, diethylene glycol monobutyl ether, ethyl carbitol acetate, ethylene glycol, ethylene glycol monohexyl ether, methoxy-2-propanol, ethoxylated-2 -propanol, 1 -butoxy-2-propanol, 1-phenoxy-2-propanol, propylene glycol monoacetate, propylene glycol diacetate, propylene glycol-1-monomethyl ether-2-acetic acid Ester, propylene glycol-1-monoethyl ether-2-acetate, dipropylene glycol, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, 4-hydroxy-4.methyl-2·pentanone, 2-(2-ethoxyl) Propyl alcohol) propanol, methyl lactate, lactate-40, 200841093 ethyl ester, η-propyl lactate, η-butyl lactate, isoamyl lactate and other solvents with low surface tension; these solvents are usually used One type or a mixture of two or more types is used. These solvents are generally preferably 80% by mass in an organic solvent, more preferably 60% by mass or less, because the polyacrylic acid or polyimine is generally low in solubility. Further, if it is desired to improve the uniformity of the coating film, it is preferably 5% by mass or more, more preferably 20% by mass or more in the organic solvent. The liquid crystal alignment agent of the present invention may contain an additive component in addition to the (A) component, the (Β) component, and the above organic solvent, within a range not impairing the effects of the present invention. The additive component may, for example, be a compound for improving the adhesion between the liquid crystal alignment film and the substrate, or a surfactant for improving the flatness of the coating film. Specific examples of the compound which improves the adhesion between the coating film and the substrate can be expressed as follows. For example, 3-aminopropyltrimethoxydecane, 3-aminopropyltriethoxydecane, 2-aminopropyltrimethoxydecane, 2-aminopropyltriethoxydecane, N- ( 2-Aminoethyl)-3-aminopropyltrimethoxydecane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxydecane, 3-propylpropyl Dimethoxylate, 3-propylpropyldiethoxylate, N.ethoxycarbonyl-3-aminopropyltrimethoxydecane, N-ethoxycarbonyl-3-aminopropyl Triethoxy decane, N-triethoxydecylpropyltriethylenetriamine, N-trimethoxydecylpropyltriethylenetriamine, 10-trimethoxydecyl-1,4, 7-triazanonane, ίο-triethoxydecyl-1,4,7-triazadecane, 9-trimethoxydecyl-3,6-diazaindolyl acetate, 9-Triethoxy sulfhydryl-3,6-diazaindolyl acetate, N-nodal-3-aminopropyltrimethoxydecane, N-benzyl-3-aminopropyl Triethoxy decane, N-benzene-41 - 200841093 -3-aminopropyltrimethoxy decane, N-phenyl-3-aminopropyltriethoxy decane, N-bis (oxyethylene) )-3-aminopropyl three A functional decane-containing compound such as methoxydecane or N-bis(oxyethylene)-3-aminopropyltriethoxydecane. When the compound of the temple is added, the effect of the dense lifting can be obtained, and from the viewpoint of not lowering the alignment property of the liquid crystal, it is preferably 1 to 30 parts by mass based on 1 part by mass of the component (A). More preferably, it is 1 to 20 parts by mass, and particularly preferably 1 to 10 parts by mass. The surfactant used for improving the flatness of the coating film may, for example, be a fluorine-based surfactant, a polyfluorene-based surfactant, or a nonionic surfactant. More specifically, for example, F-TOP EF301, EF3 03, EF352 (above, TOHKEM PRODUCT), MEGAFAC F171, F173, R-30 (above, manufactured by Otsuka Ink Co., Ltd.), FULORD FC430, F431 (for example) Above, Sumitomo 3M Company, AsahiGuard AG710, Surf Ion S-382, SC101, SC102, SC103, SC104, SC105, SC106 (above, Asahi Glass Co., Ltd.). The proportion of the surfactant to be used is preferably 0.01 to 2 parts by mass, more preferably 0.01 to 1 part by mass, per 100 parts by mass of the polymer component. <Liquid Crystal Alignment Film-Liquid Crystal Display Element> The liquid crystal alignment treatment agent of the present invention can be applied onto a substrate, and after firing, it can be subjected to alignment treatment by honing treatment or light irradiation, or can be performed in a vertical alignment application or the like. The alignment treatment is used as a liquid crystal alignment film. In this case, the substrate to be used may be a substrate having high transparency, and -42 to 200841093 is not particularly limited, and a plastic substrate such as a glass substrate, an acrylic substrate or a polycarbonate substrate can be used. Further, it is preferable to use a substrate on which an ITO electrode or the like for liquid crystal driving is formed, from the viewpoint of simplification of the process, and a reflective liquid crystal display element can be opaque using a germanium wafer or the like only on one side of the substrate. For the electrode at this time, a material that reflects light such as aluminum can also be used. The coating method of the liquid crystal alignment agent is not particularly limited, but industrially, it is generally a method of screen printing, offset printing, flexographic printing, ink jetting or the like. Other coating methods are immersion, roll coater, slit coater, spin coater, etc., and can be used according to the purpose. The firing after application of the liquid crystal alignment agent can be carried out at any temperature of 100 to 3 50 ° C, but is preferably 120 to 300 ° C, more preferably 150 to 250 ° C. This baking can be performed in a hot plate, a hot air circulation furnace, an infrared furnace, or the like. The thickness of the coating film after firing is too thick to be detrimental to the power consumption of the liquid crystal display element. If it is too thin, the reliability of the liquid crystal display element may be lowered, so it is preferably 5 to 300 nm. Good for 10~100nm. When the liquid crystal is horizontally aligned or tilted, it is treated by honing or polarized ultraviolet light irradiation. In the liquid crystal display device of the present invention, a substrate having a liquid crystal alignment film is obtained from the liquid crystal alignment treatment agent of the present invention, and a liquid crystal cell is produced by a conventional method to obtain a liquid crystal display element. In the case of an example of the production of a liquid crystal cell, a pair of substrates on which a liquid crystal alignment film has been formed is prepared, and a separator is interposed on the liquid crystal alignment film of one of the substrates, and the other substrate is bonded to the inside of the liquid crystal alignment film. -43- 200841093 A method of sealing after liquid crystal injection under reduced pressure; or a method of sealing a substrate after laminating liquid crystal on a liquid crystal alignment film surface on which a separator is dispersed, and then sealing. The thickness of the separator at this time is preferably from 1 to 30 m, more preferably from 2 to 10 #m. In this way, the liquid crystal display element produced by using the liquid crystal alignment agent of the present invention can be made into a liquid crystal display having excellent tilt stability, suitable for a germanium element, an STN element, a TFT liquid crystal element, and more suitable for vertical. An alignment type liquid crystal display element or the like. [Embodiment] Hereinafter, the present invention will be described in more detail by way of Examples, but it is not limited to these Examples. The abbreviations of the compounds used in this example are as follows. (tetracarboxylic dianhydride)

CBDA: 1,2,3,4-環丁院四殘酸二酐 BODA:雙環[3,3,0]辛烷-2,4,6,8-四羧酸二酐 [化 28]CBDA: 1,2,3,4-cyclobutanine tetraresin dianhydride BODA: bicyclo[3,3,0]octane-2,4,6,8-tetracarboxylic dianhydride [Chem. 28]

(二胺) p-PDA : p-苯撐二胺 -44- 200841093 DBA : 3,5-二胺苯甲酸 DADPA: 4,4,_二胺基二苯基胺 AP18 ·· 4_ (十八基氧基)-1,3-苯撐二胺 PCH : 1,3-二胺基-4-[4- ( 4-庚基環己基)苯氧基]苯 [化 29](Diamine) p-PDA : p-phenylenediamine-44- 200841093 DBA : 3,5-diaminobenzoic acid DADPA: 4,4,-diaminodiphenylamine AP18 ·· 4_ (18-base Oxy)-1,3-phenylenediamine PCH : 1,3-diamino-4-[4-(4-heptylcyclohexyl)phenoxy]benzene [29]

H2NH2N

DADPA API 8DADPA API 8

(氧雜環丁烷) 氧雜環丁烷(A) : OXT_221 (東亞合成公司製) 氧雜環丁烷(B) :OX-SQ-H (東亞合成公司製) 氧雜環丁烷(C ) : ΟΧ-SC (東亞合成公司製) -45- 200841093 [化 30] 氧雜環丁烷A (OX丁一 2 2 1)(oxetane) oxetane (A) : OXT_221 (manufactured by Toagosei Co., Ltd.) Oxetane (B): OX-SQ-H (manufactured by Toagosei Co., Ltd.) Oxetane (C) ) : ΟΧ-SC (manufactured by Toagosei Co., Ltd.) -45- 200841093 [Chem. 30] Oxetane A (OX Ding-2 2 1)

氧雜環丁烷B (OX-SQ-H)Oxetane B (OX-SQ-H)

氧雜環丁烷C (〇X — SC)Oxetane C (〇X — SC)

(環氧系交聯性化合物) 環氧A : YH-4 3 4L (東都化成公司製) 環氧B :艾伯利得GT-401 ( 4官能脂環式環氧樹脂) (DAICEL化學公司製);環氧化丁烷四羧酸肆-(3-環己 烯基甲基)修飾ε -己內酯 -46- 200841093 [化 31](Epoxy-based cross-linking compound) Epoxy A: YH-4 3 4L (manufactured by Tohto Kasei Co., Ltd.) Epoxy B: Aberdeen GT-401 (4-functional alicyclic epoxy resin) (manufactured by DAICEL Chemical Co., Ltd.) Epoxidized butane tetracarboxylic acid ruthenium-(3-cyclohexenylmethyl) modified ε-caprolactone-46- 200841093 [Chem. 31]

(有機溶劑) NMP : N-甲基-2-吡咯烷酮 BCS : 丁基溶纖劑 &lt;聚醯亞胺的分子量測量&gt; 合成例中聚醯亞胺的分子量,係使用 司製之常溫凝膠滲透層析法(GPC )裝懦 Shodex 公司製管柱(KD-803、KD-805) 量。(Organic solvent) NMP : N-methyl-2-pyrrolidone BCS : butyl cellosolve <Molecular weight measurement of polyimine > The molecular weight of polyimine in the synthesis example is a room temperature gel permeation layer The analytical method (GPC) is equipped with a pipe column (KD-803, KD-805) manufactured by Shodex.

管柱溫度:5 0 °C 溶離液:N,N’-二甲基甲醯胺(作爲 水合物(LiBr· H2O)爲 30mmol/L、碟冒 磷酸)爲30mmol/L、四氫呋喃(THF ) % 流速:1.0ml /分鐘 檢重線製作用標準試樣:東曹公司_ 氧乙烷(分子量約90 00,000、150,000、 )、及 Polymer Laboratories 公司製聚乙 12,000、 4,000、 1,000) 〇 SENSHU科學公 l (SSC-7200)、 ’依下述作法測 添加劑,溴化鋰-爱•無水結晶(〇 · I 1 0 m 1 / L ) ^ TSK標準聚環 1 00,000、3 0,000 二醇(分子量約 -47- 200841093 &lt;醯亞胺化率的測量&gt; 合成例中之聚醯亞胺的醯亞胺化率如下述作法 將聚醯亞胺粉末20mg,放進NMR試樣管(草野科 製 NMR塡充柱採樣管標準 0 5mm),添加重氫 基亞礪(DMSO-d6、〇.〇5%TMS 混合品)0.53ml, 音波使其完全地溶解。於此塡充柱內溶液用曰 DATUM公司 NMR測量器(JNW-ECA5 00 )測量 的質子NMR。醯亞胺化率,係以醯亞胺化前後之萍 化的結構的質子爲基準質子來決定,此質子的波_ 、與出現在9.5〜lO.Oppm附近之來自醯胺酸的NH 子波峰積算値,藉由以下式計算得到。 測量, •學公司 化二甲 施加超 本電子 500MHz :自未變 r積算値 基的質Column temperature: 50 °C Dissolution: N,N'-dimethylformamide (30 mmol/L as hydrate (LiBr·H2O), phosphoric acid as dish) 30 mmol/L, tetrahydrofuran (THF) % Flow rate: 1.0ml / minute Standard sample for the production of checkweighing lines: Tosoh Corporation _ Oxygenethane (molecular weight about 90 00,000, 150,000, ), and Polyethylene Laboratories Inc. Polyethylene 12,000, 4,000, 1,000) 〇SENSHU Science (SSC-7200), 'Test additive according to the following method, lithium bromide-love•anhydrous crystal (〇·I 1 0 m 1 / L ) ^ TSK standard polycyclic ring 1,00,000, 3,000 diol (molecular weight about -47- 200841093 &lt;Measurement of yttrium imidation ratio&gt; The ruthenium imidation ratio of the polyimine in the synthesis example was as follows. 20 mg of the polyimide pigment was placed in the NMR sample tube (the NMR sputum column manufactured by Kusano) The sampling tube standard is 0 5mm), 0.53ml of heavy hydrogen hydrazine (DMSO-d6, 〇.〇5% TMS mixture) is added, and the sound wave is completely dissolved. The solution in the sputum column is measured by NMRDATUM NMR. Proton NMR measured by JNW-ECA5 00. The rate of oxime imidization is based on the structure of the acetylation before and after imidization. The proton is determined by the reference proton, and the wave of this proton is calculated by the following formula with the NH sub-peak derived from lysine which appears near 9.5~10. Oppm. Measurement, • Ultra-electronic 500MHz: the quality of the enthalpy based on the unconverted r

醯亞胺化率(%) = ( 1- α · x/y) xlOO 在上述式中,x爲來算醯胺酸的NH基的質 算値,y爲基準質子的波峰積算値,α爲聚醯胺 胺化率爲〇% )時之相對於醯胺酸的ΝΗ基質子1 質子的個數比例。 波峰積 (醯亞 的基準 (合成例1 ) 使 CBDA ( 5 . 1 g,2 6. Ommol ) 、p-PD A ( 2 3.4 m m ο 1 ) 、AP18( 0.98g,2.6mmol)於 NMP ( 中混合,以2 51使其反應6小時,得到聚醯胺酸醯 imidization rate (%) = ( 1- α · x / y) xlOO In the above formula, x is the mass 値 of the NH group of the proline, y is the peak of the reference proton, α, α is The ratio of the number of protons of the ruthenium proton 1 to the valeric acid when the polyamine amination rate is 〇%). The peak product (the synthesis example 1) makes CBDA (5.1 g, 2 6. Ommol), p-PD A (2 3.4 mm ο 1 ), AP18 (0.98 g, 2.6 mmol) in NMP (in the middle) Mix and react with 2 51 for 6 hours to obtain polylysine

2.53g , 81.5g ) 溶液(A -48- 200841093 )。聚醯胺酸溶液(A )的數平均分子量爲22000,重量 平均分子量爲78900。 (合成例2 ) 使 CBDA ( 3.04g,1 5.5 mmo 1 ) 、p-PD A ( 1 . 5 6 g, 14.4mmol) 、PCH ( 0.61g,1.6mmol)於 NMP ( 22.0g)中 混合,以2 51使其反應5小時,得到聚醯胺酸溶液(B ) 。聚醢胺酸溶液(B)的數平均分子量爲25000,重量平 均分子量爲94000。 (合成例3 ) 使 BODA ( 1 6.9 g,6 8mmol ) 、p-PD A ( 8.74g, 81 mmol ) 、PCH ( 3.43g,9mmol)於 NMP ( 100」g)中混 合,以 40 °C使其反應 3小時後,加入 CBDA ( 4. Ig, 21 mmol)與NMP ( 52.2g),以4 0 °C使其反應3小時,得 到聚醯胺酸溶液(C )。此聚醯胺酸(C )的數平均分子量 爲20500,重量平均分子量爲76500。 (合成例4 ) 使 BODA ( 150.1g,6 00mmol) 、DBA ( 60.9g, 400mmol ) 、PCH ( 152.2g,400mmol )於 NMP ( 1290g ) 中混合,以80°C使其反應5小時後,加入CBDA ( 38.8g ,198mmol)與 NMP (32 0g),以 4〇t:使其反應 3 小時, 得到聚醯胺酸溶液(D )。此聚醯辉酸(D )的數平均分 -49- 200841093 子量爲24400,重量平均分子量爲98500。 (合成例5 ) 於合成例3所得到的聚醯胺酸溶液(C ) ( 1 3 0.3 g ) 中加入NMP稀釋成6質量%後,加入乙酸酐(15.6g)、 吡啶(12.1g)作爲醯亞胺化觸媒,以80°C使其反應3小 時,將此反應溶液投入甲醇(1 600ml )中,過濾所得到的 沈澱物,將此沈澱物用甲醇洗淨,以1 00 °C減壓乾燥而得 到聚醯亞胺粉末(E )。此聚醯亞胺的醯亞胺化率爲5 4 % ,數平均分子量爲18300,重量平均分子量爲453 00。 (合成例6 ) 於合成例4所得到的聚醯胺酸溶液(D ) ( 600.2g ) 中加入NMP稀釋成6質量%後,加入乙酸酐(63.9g )、 吡啶(49.6g )作爲醯亞胺化觸媒,以80°C使其反應3小 時,將此反應溶液投入甲醇(7700ml )中,過濾所得到的 沈澱物,將此沈澱物用甲醇洗淨,以1 〇〇 °C減壓乾燥而得 到聚醯亞胺粉末(F )。此聚醯亞胺的醯亞胺化率爲5 7% ,數平均分子量爲23,000,重量平均分子量爲80,200。 (合成例7 ) 於合成例4所得到的聚醯胺酸溶液(D ) ( 101.2g) 中加入NMP稀釋成6質量%後,加入乙酸酐(21.3g )、 啦啶(16.5g)作爲醯亞胺化觸媒,以9(rc使其反應3小 -50- 200841093 時,將此反應溶液投入甲醇(1 300ml )中,過濾所得到的 沈澱物,將此沈澱物用甲醇洗淨,以100 °C減壓乾燥而得 到聚醯亞胺粉末(G )。此聚醯亞胺的醯亞胺化率爲8 1 % ,數平均分子量爲20400,重量平均分子量爲63 000。 (實施例1 ) 於合成例1所得到的聚醯胺酸溶液(A ) ( 6.00g )中 ,加入氧雜環丁烷(A) (O.llg) 、NMP(4.76g) 、BCS (2 · 5 3 g )後攪拌,得到液晶配向處理劑[1 ]。 將上述所得到的液晶配向處理劑[1]旋轉塗佈於3 cm X 4cm附有ΙΤΌ電極之基板的ITO面上,以80°C加熱處理5 分鐘、以23 0°C加熱處理30分鐘後得到膜厚100nm的聚 醯亞胺薄膜。將塗膜面用滾筒徑120mm、人造絲布的硏磨 裝置,以回轉數 700rpm、移動速度 40mm/Sec、壓入量 0.3mm的條件進行硏磨處理,得到附有液晶配向膜之基板 。準備2片此附有液晶配向膜之基板,將液晶配向膜面朝 向內側挾入5 0//m的隔板,在硏磨方向爲逆向的狀態下組 合,用密封劑黏著周圍而製作空盒,在此空盒中藉由減壓 注入法注入液晶ZLI-2293 ( Merk Japan公司製),封閉注 入口後得到反平行配向的向列液晶盒。 關於此液晶盒,液晶注入後的初期、及以120 °C加熱 處理5小時後的各傾斜角,用傾斜角測量裝置(EL SIC ON 公司製樣機PAS-301)於室溫測量,關於初期及各加熱 處理後的液晶盒,用偏光顯微鏡觀察確認液晶的配向均勻 -51 - 200841093 性的結果,任何液晶盒皆無配向不良,液晶 〇 此外,關於除了硏磨處理的壓入量定爲 與上述相同作法所製作的液晶盒,測量液晶 及以120 °c加熱處理5小時後的各傾斜角, 觀察確認液晶的配向均勻性的結果,任何液 不良,液晶皆均句地配向。 傾斜角的測量結果,列示於表1。 (實施例2) 於合成例1所得到的聚醯胺酸溶液(A : ,加入氧雜環丁烷(A ) ( 0.06g ) 、NMP ( (2.3 5g )後攪拌,得到液晶配向處理劑[2]。 使用所得到的液晶配向處理劑[2],與實 製作液晶盒,測量硏磨處理的壓入量〇.3mm 的初期、及以120°C加熱處理5小時後的各 初期及各加熱處理後的液晶盒,用偏光顯微 晶的配向均勻性的結果,任何液晶盒皆無配 皆均勻地配向。 此外,關於除了硏磨處理的壓入量定爲 與上述相同作法所製作的液晶盒’測量液晶 及以120 °C加熱處理5小時後的各傾斜角, 觀察確認液晶的配向均勻性的結果’任何液 不良,液晶皆均勻地配向。 皆均勻地配向 0.1 mm,其餘 注入後的初期 用偏光顯微鏡 晶盒皆無配向 )(6.05g)中 4.05g ) 、BCS 施例1同樣地 之液晶注入後 傾斜角,關於 鏡觀察確認液 向不良,液晶 0.1 mm,其餘 注入後的初期 用偏光顯微鏡 晶盒皆無配向 -52- 200841093 傾斜角的測量結果,列示於表1。 (實施例3 ) 於合成例1所得到的聚醯胺酸溶液(A ) (6.00g)中2.53g, 81.5g) solution (A -48- 200841093). The polyaminic acid solution (A) had a number average molecular weight of 22,000 and a weight average molecular weight of 78,900. (Synthesis Example 2) CBDA (3.04 g, 1 5.5 mmo 1 ), p-PD A (1.56 g, 14.4 mmol), and PCH (0.61 g, 1.6 mmol) were mixed in NMP (22.0 g) to 2 51 was allowed to react for 5 hours to obtain a polyaminic acid solution (B). The polyaminic acid solution (B) had a number average molecular weight of 25,000 and a weight average molecular weight of 94,000. (Synthesis Example 3) BODA (16.9 g, 6 8 mmol), p-PD A (8.74 g, 81 mmol), and PCH (3.43 g, 9 mmol) were mixed in NMP (100" g) at 40 °C After reacting for 3 hours, CBDA (4 Ig, 21 mmol) and NMP (52.2 g) were added, and the mixture was reacted at 40 ° C for 3 hours to obtain a polyaminic acid solution (C). The polyamic acid (C) had a number average molecular weight of 20,500 and a weight average molecular weight of 76,500. (Synthesis Example 4) BODA (150.1 g, 6 00 mmol), DBA (60.9 g, 400 mmol), and PCH (152.2 g, 400 mmol) were mixed in NMP (1290 g), and reacted at 80 ° C for 5 hours, and then added. CBDA (38.8 g, 198 mmol) and NMP (32 0 g) were reacted for 4 hours at 4 Torr to obtain a polyaminic acid solution (D). The number average fraction of the polyfluorene acid (D) was -24-200841093, and the weight average molecular weight was 98,500. (Synthesis Example 5) After the NMP was added to the polyaminic acid solution (C) (1 3 0.3 g) obtained in Synthesis Example 3 and diluted to 6 mass%, acetic anhydride (15.6 g) and pyridine (12.1 g) were added as The ruthenium imidization catalyst was reacted at 80 ° C for 3 hours, and the reaction solution was poured into methanol (1 600 ml), and the obtained precipitate was filtered, and the precipitate was washed with methanol at 100 ° C. The polyimine powder (E) was obtained by drying under reduced pressure. The polyamidimide had a ruthenium iodide ratio of 5 4 %, a number average molecular weight of 18,300, and a weight average molecular weight of 453 00. (Synthesis Example 6) After the NMP was added to the polyaminic acid solution (D) (600.2 g) obtained in Synthesis Example 4 and diluted to 6 mass%, acetic anhydride (63.9 g) and pyridine (49.6 g) were added as a ruthenium. The aminated catalyst was reacted at 80 ° C for 3 hours, and the reaction solution was poured into methanol (7700 ml), and the obtained precipitate was filtered, and the precipitate was washed with methanol and decompressed at 1 ° C. Dry to obtain a polyimide pigment (F). The polyamidimide had a ruthenium iodide ratio of 5 7%, a number average molecular weight of 23,000, and a weight average molecular weight of 80,200. (Synthesis Example 7) After the NMP was added to the polyamidic acid solution (D) (101.2 g) obtained in Synthesis Example 4 and diluted to 6 mass%, acetic anhydride (21.3 g) and pyridine (16.5 g) were added as hydrazine. For the imidization catalyst, the reaction solution was poured into methanol (1 300 ml) at 9 (rc) to react 3 small - 50 to 200841093, and the obtained precipitate was filtered, and the precipitate was washed with methanol to The polyilylimide powder (G) was obtained by drying under reduced pressure at 100 ° C. The polyamidimide had a ruthenium iodide ratio of 81%, a number average molecular weight of 20,400, and a weight average molecular weight of 63 000. (Example 1 To the polyproline solution (A) (6.00 g) obtained in Synthesis Example 1, oxetane (A) (O.llg), NMP (4.76 g), BCS (2 · 5 3 g) were added. After stirring, a liquid crystal alignment treatment agent [1] was obtained. The liquid crystal alignment treatment agent [1] obtained above was spin-coated on an ITO surface of a substrate of 3 cm X 4 cm with a ruthenium electrode, and heat-treated at 80 ° C. After 5 minutes of heat treatment at 23 ° C for 30 minutes, a polyimide film having a thickness of 100 nm was obtained. The coating surface was honed by a boring mill with a drum diameter of 120 mm and a rayon cloth. The pm, the moving speed of 40 mm/Sec, and the press-in amount of 0.3 mm were honed to obtain a substrate with a liquid crystal alignment film. Two substrates with the liquid crystal alignment film were prepared, and the liquid crystal alignment film was turned inward. The separator of 5 0/m is combined in a state in which the honing direction is reversed, and an empty box is formed by adhering the sealant to the periphery, and liquid crystal ZLI-2293 is injected into the empty box by a vacuum injection method (Merk Japan Co., Ltd.) In order to obtain an anti-parallel alignment nematic liquid crystal cell after closing the injection port, the tilt angle measuring device (EL) is used for the liquid crystal cell at the initial stage after liquid crystal injection and at each tilt angle after heat treatment at 120 ° C for 5 hours. SIC ON company sampler PAS-301) was measured at room temperature, and the liquid crystal cell after the initial and each heat treatment was observed by a polarizing microscope to confirm the uniformity of the liquid crystal alignment - 51 - 200841093. Further, regarding the liquid crystal cell prepared by the same method as described above except for the honing treatment, the liquid crystal and each tilt angle after heat treatment at 120 ° C for 5 hours were observed, and the liquid crystal distribution was observed and confirmed. As a result of the uniformity, any liquid was poor, and the liquid crystals were uniformly aligned. The measurement results of the tilt angle are shown in Table 1. (Example 2) The polyaminic acid solution obtained in Synthesis Example 1 (A: , After adding oxetane (A) (0.06 g) and NMP (2.35 g), the mixture was stirred to obtain a liquid crystal alignment treatment agent [2]. Using the obtained liquid crystal alignment treatment agent [2], a liquid crystal cell was fabricated. The liquid crystal cell after the initial measurement of the honing treatment, the initial stage of the honing treatment, the heat treatment at 120 ° C for 5 hours, and the liquid crystal cell after each heat treatment were used, and any liquid crystal was used as a result of the uniformity of the alignment of the polarized microcrystals. The boxes are evenly aligned without any matching. Further, regarding the amount of press-in which is the same as the above-described immersion treatment, the liquid crystal cell produced by the same method as described above was measured for liquid crystal and each tilt angle after heat treatment at 120 ° C for 5 hours, and the result of observing the alignment uniformity of the liquid crystal was observed. Any liquid is poor, and the liquid crystals are evenly aligned. All of them were evenly aligned to 0.1 mm, and the initial polarized microscope cartridges were not aligned in the initial injection (4.05 g) (4.05 g), and the BCS Example 1 was similarly tilted after liquid crystal injection, and the liquid observation was confirmed by mirror observation. The liquid crystal was 0.1 mm, and the initial polarization microscope collimator after the injection was not aligned. The measurement results of the tilt angle of -52-200841093 are shown in Table 1. (Example 3) In the polyaminic acid solution (A) (6.00 g) obtained in Synthesis Example 1.

,加入氧雜環丁烷(B) ( 0.03g) 、NMP(3.61g) 、BCS (2.21g)後攪拌,得到液晶配向處理劑[3]。 使用所得到的液晶配向處理劑[3],與實施例1同樣地 製作液晶盒,測量硏磨處理的壓入量〇.3mm之液晶注入後 的初期、及以1 20°C加熱處理5小時後的各傾斜角,關於 初期及各加熱處理後的液晶盒,用偏光顯微鏡觀察確認液 晶的配向均勻性的結果,任何液晶盒皆無配向不良,液晶 皆均勻地配向。 此外,關於除了將壓入量定爲0.1mm,其餘與上述相 同作法所製作的液晶盒,測量液晶注入後的初期及以1 2 0 °C加熱處理5小時後的各傾斜角,用偏光顯微鏡觀察確認 液晶的配向均勻性的結果,任何液晶盒皆無配向不良,液 晶皆均勻地配向。 傾斜角的測量結果,列示於表1。 (實施例4)After adding oxetane (B) (0.03 g), NMP (3.61 g), and BCS (2.21 g), the mixture was stirred to obtain a liquid crystal alignment treatment agent [3]. Using the obtained liquid crystal alignment treatment agent [3], a liquid crystal cell was produced in the same manner as in Example 1, and the initial amount after the liquid crystal injection of the honing treatment was measured, and the heat treatment was performed at 10 ° C for 5 hours. After the initial tilting angle and the liquid crystal cell after the heat treatment, the alignment uniformity of the liquid crystal was observed by a polarizing microscope. As a result, no alignment failure was observed in any of the liquid crystal cells, and the liquid crystals were uniformly aligned. Further, regarding the liquid crystal cell produced by the same method as described above except that the press-in amount was set to 0.1 mm, the initial angle after liquid crystal injection and each tilt angle after heat treatment at 150 ° C for 5 hours were measured, and a polarizing microscope was used. As a result of observing the alignment uniformity of the liquid crystal, any of the liquid crystal cells had no misalignment, and the liquid crystals were evenly aligned. The measurement results of the tilt angle are shown in Table 1. (Example 4)

於合成例2所得到的聚醯胺酸溶液(B) ( 6.00g)中 ,加入氧雜環丁烷(A) ( 〇.12g) 、NMP ( 3.61g) 、BCS (2.4g)後攪拌,得到液晶配向處理劑[4]。 使用所得到的液晶配向處理劑[4],與實施例1同樣地 -53- 200841093 製作液晶盒’測量硏磨處理的壓入量〇.3mm之液晶注入後 的初期、及以1 20 °C加熱處理5小時後的各傾斜角,關於 初期及各加熱處理後的液晶盒,用偏光顯微鏡觀察確認液 晶的配向均勻性的結果,任何液晶盒皆無配向不良,液晶 皆均勻地配向。 傾斜角的測量結果,列示於表1。 (實施例5 ) 於合成例2所得到的聚醯胺酸溶液(B ) ( 6.02g )中To the polyproline solution (B) (6.00 g) obtained in Synthesis Example 2, oxetane (A) (〇.12g), NMP (3.61g), and BCS (2.4g) were added, followed by stirring. A liquid crystal alignment treatment agent [4] was obtained. Using the obtained liquid crystal alignment treatment agent [4], in the same manner as in Example 1, -53-200841093, the liquid crystal cell was measured, and the amount of press-in which the honing treatment was measured was 〇3 mm, and the initial stage after liquid crystal injection was performed, and at 20 ° C. Each of the tilt angles after the heat treatment for 5 hours was used to observe the uniformity of alignment of the liquid crystals with respect to the liquid crystal cell after the initial treatment and the heat treatment, and any liquid crystal cell was not misaligned, and the liquid crystals were uniformly aligned. The measurement results of the tilt angle are shown in Table 1. (Example 5) In the polyaminic acid solution (B) (6.02 g) obtained in Synthesis Example 2

,加入氧雜環丁烷(B) ( 0.03g ) 、NMP(2.41g) 、BCS (2.10g )後攪拌,得到液晶配向處理劑[5]。 使用所得到的液晶配向處理劑[5],與實施例1同樣地 製作液晶盒,測量硏磨處理的壓入量0 · 3 mm之液晶注入後 的初期、及以1 20°C加熱處理5小時後的各傾斜角,關於 初期及各加熱處理後的液晶盒,用偏光顯微鏡觀察確認液 晶的配向均勻性的結果,任何液晶盒皆無配向不良,液晶 皆均勻地配向。 傾斜角的測量結果,列示於表1。 (比較例1 ) 於合成例1所得到的聚醯胺酸溶液(A) ( 6.〇〇g)中 ,加入NMP ( 3.06g ) 、BCS ( 2.12g )後攪拌,得到液晶 配向處理劑[6]。 使用所得到的液晶配向處理劑[6],與實施例1同樣地 -54- 200841093 製作液晶盒,測量硏磨處理的壓入量〇 . 3 m m之液晶注入後 的初期、及以1 20°C加熱處理5小時後的各傾斜角,關於 初期及各加熱處理後的液晶盒,用偏光顯微鏡觀察確認液 晶的配向均勻性的結果,任何液晶盒皆無配向不良,液晶 皆均勻地配向。 傾斜角的測量結果,列示於表1。 (比較例2 ) 於合成例2所得到的聚醯胺酸溶液(B ) ( 6 · 0 1 g )中 ,加入NMP ( 2.01g ) 、:BCS ( 1.99g )後攪拌,得到液晶 配向處理劑[7 ]。 使用所得到的液晶配向處理劑[7],與實施例1同樣地 製作液晶盒,測量硏磨處理的壓入量0 · 3 mm之液晶注入後 的初期、及以1 2 0 °C加熱處理5小時後的各傾斜角’關於 初期及各加熱處理後的液晶盒,用偏光顯微鏡觀察確認液 晶的配向均勻性的結果,任何液晶盒皆無配向不良’液晶 皆均勻地配向。 傾斜角的測量結果,列示於表1 ° (比較例3) 於合成例1所得到的聚醯胺酸溶液(A ) ( 6.0 〇 g )中 ,加入環氧(A) (O.Ug) 、NMP(4.75g) 、BCS( 2.5 2g)後攪拌,得到液晶配向處理劑[8]。 使用所得到的液晶配向處理劑[8],與實施例1同樣地 -55- 200841093 製作液晶盒,測量硏磨處理的壓入量〇 . 3 m m之液晶注入後 的初期、及以1 20°C加熱處理5小時後的各傾斜角,於此 液晶盒的初期狀態,觀察到液晶注入時液晶朝向液晶流動 方向配向之所謂的流動配向,而且,熱處理後的各階段中 此流動配向亦未消除,再加上,因爲熱處理而發生 discrimination line,因爲發生如此的配向不良,故無法測 量此液晶盒的傾斜角。 而且,測量除了將壓入量定爲0.1mm,其餘與上述相 同作法所製作的液晶盒之液晶注入後的初期及以1 20 °C加 熱處理5小時後的傾斜角,於初期狀態,看到流動配向, 熱處理後此流動配向亦未消除,再加上,發生 discrimination line,因此無法測量傾斜角。 傾斜角的測量結果,列示於表1。 (比較例4 ) 於合成例1所得到的聚醯胺酸溶液(A) ( 6.05g)中 ,力Q 入環氧(A ) ( 0.06g ) 、NMP ( 4.03g ) 、BCS ( 2.3 4g)後攪拌,得到液晶配向處理劑[9]。 使用所得到的液晶配向處理劑[9],與實施例1同樣地 製作液晶盒,測量硏磨處理的壓入量之液晶注入後 的初期、及以1 20 °C加熱處理5小時後的各傾斜角’關於 初期的液晶盒,藉由偏光顯微鏡觀察確認液晶的配向均勻 性的結果,無配向不良,液晶均勻地配向,但以1 2〇°C加 熱處理 5小時後,發生discrimination line,因此無法測 -56- 200841093 量以1 2 0 °C加熱處理5小時後的液晶盒的傾斜角。 而且,測量除了將壓入量定爲0.1mm,其餘與上述相 同作法所製作的液晶盒之液晶注入後的初期及以1 20 °C加 熱處理5小時後的傾斜角的結果,於初期狀態,看到流動 配向’熱處理後此流動配向亦未消除,再加上,發生 discrimination line,因此無法測量傾斜角。 傾斜角的測量結果,列示於表1。 (比較例5 ) 於合成例1所得到的聚醯胺酸溶液(A) (6.00g)中 ,力口 入環氧(B) (0.06g) 、NMP (4.0 2g) 、BCS( 2 · 3 5 g )後攪拌,得到液晶配向處理劑[1 〇 ]。 使用所得到的液晶配向處理劑[1 0],與實施例1同樣 地製作液晶盒,測量硏磨處理的壓入量0.3 mm之液晶注入 後的初期、及以1 2 0 °C加熱處理5小時後的各傾斜角,關 於初期的液晶盒,藉由偏光顯微鏡觀察確認液晶的配向均 勻性的結果,無配向不良,液晶均勻地配向,但以120 °C 加熱處理5小時後,發生discrimination line,因此無法 測量以1 20°C加熱處理5小時後的液晶盒的傾斜角。 而且,測量除了將壓入量定爲0.1mm,其餘與上述相 同作法所製作的液晶盒之液晶注入後的初期及以1 20 °C加 熱處理5小時後的傾斜角的結果,於初期狀態,看到流動 配向,熱處理後此流動配向亦未消除,再加上,發生 discrimination line,因此無法測量傾斜角。 -57- 200841093 傾斜角的測量結果,列示於表i。 (實施例6) 於合成例5所得到的聚醯亞胺粉末(e ) ( 2 · 9 1 g )中 加入NMP ( 1 7· 1 g ),以80°C攪拌40小時使其溶解後,於 此ί谷液中加入氧雜環丁院(A ) ( 〇 · 6 0 g ) 、Ν Μ P ( 1 2.2 g ) 、B C S ( 2 5 · 7 g )後攪拌,得到液晶配向處理劑[i丨]。 φ 使用所得到的液晶配向處理劑[11],除了液晶爲 ‘ MLC-660 8 ( Merk Japan公司製)以外,其餘與實施例j 同樣地製作液晶盒’接著測量硏磨處理的壓入量〇 · 3 mm之 液晶注入後的初期、及以1 20°C加熱處理5小時後的傾斜 角’關於初期及各加熱處理後的液晶盒,用偏光顯微鏡觀 察確認液晶的配向均勻性的結果,任何液晶盒皆無配向不 良,液晶皆均勻地配向。 此外,關於除了硏磨處理的壓入量定爲0.1 mm,其餘 φ 與上述相同作法所製作的液晶盒,測量液晶注入後的初期 及以1 20 °C加熱處理5小時後的傾斜角,關於此等液晶盒 ,用偏光顯微鏡觀察確認液晶的配向均勻性的結果,任何 液晶盒皆無配向不良,液晶皆均勻地配向。 (實施例7) 於合成例5所得到的聚醯亞胺粉末(E) (3.05g)中 加入NMP ( 18.0g),以80°C攪拌40小時使其溶解後,於 此溶液中加入氧雜環丁烷(A) ( 〇.31g) 、NMP ( 6.65 g) -58- 200841093 、BCS ( 28.0g )後攪拌,得到液晶配向處理劑[12]。 使用所得到的液晶配向處理劑[1 2],除了液晶爲 MLC-660 8 ( Merk Japan公司製)以外,其餘與實施例1 同樣地製作液晶盒,接著測量硏磨處理的壓入量〇.3mm之 液晶注入後的初期、及以1 20 °C加熱處理5小時後的傾斜 角,關於初期及各加熱處理後的液晶盒,用偏光顯微鏡觀 察確認液晶的配向均勻性的結果,任何液晶盒皆無配向不 良,液晶皆均勻地配向。 此外,關於除了將壓入量定爲〇. 1 mm,其餘與上述相 同作法所製作的液晶盒,測量液晶注入後的初期及以1 20 °C加熱處理5小時後的各傾斜角,關於此等液晶盒,用偏 光顯微鏡觀察確認液晶的配向均勻性的結果,任何液晶盒 皆無配向不良,液晶皆均勻地配向。 傾斜角的測量結果,列示於表1。 (實施例8) 於合成例5所得到的聚醯亞胺粉末(E ) ( 3 · 0 0 g )中 加入NMP ( 17.6g),以80°C攪拌40小時使其溶解後,於 此溶液中加入氧雜環丁烷(A ) ( 0· 1 5g ) 、NMP ( 5 ·5 1 g ) 、:BCS ( 26.3g )後攪拌,得到液晶配向處理劑[13]。 使用所得到的液晶配向處理劑[13],除了液晶爲 MLC-660 8 ( Merk Japan公司製)以外,其餘與實施例1 同樣地製作液晶盒’接著測量硏磨處理的壓入量〇 . 3 m m之 液晶注入後的初期、及以1 2 0 t:加熱處理5小時後的傾斜 -59- 200841093 角,關於初期及各加熱處理後的液晶盒,用偏光顯微鏡觀 察確認液晶的配向均勻性的結果,任何液晶盒皆無配向不 良,液晶皆均勻地配向。 此外,關於除了將壓入量定爲0.1mm,其餘與上述相 同作法所製作的液晶盒,測量液晶注入後的初期及以120 °C加熱處理5小時後的各傾斜角,關於此等液晶盒,用偏 光顯微鏡觀察確認液晶的配向均勻性的結果,任何液晶盒 皆無配向不良,液晶皆均勻地配向。 傾斜角的測量結果,列示於表1。 (實施例9) 於合成例6所得到的聚醯亞胺粉末(F) ( 3.12g)中 加入NMP(18.4g),以80°C攪拌40小時使其溶解後,於 此溶液中加入氧雜環丁烷(A ) ( 0.3 1 g ) 、NMP ( 6.80g ) 、BCS ( 28.6g)後攪拌,得到液晶配向處理劑[14]。 使用所得到的液晶配向處理劑[14],除了液晶爲 MLC-660 8 ( Merk Japan公司製)以外,其餘與實施例 i 同樣地製作液晶盒,接著測量硏磨處理的壓入量0 · 3 mm之 液晶注入後的初期、及以1 20°C加熱處理5小時後的傾斜 角’關於初期及各加熱處理後的液晶盒,用偏光顯微鏡觀 察確認液晶的配向均勻性的結果,任何液晶盒皆無配向不 良’液晶皆均勻地配向。 傾斜角的測量結果,列示於表1。 -60- 200841093 (實施例1 〇) 於合成例6所得到的聚醯亞胺粉末(F) ( 3.04g)中 加入NMP ( 17.9g),以8(TC攪拌40小時使其溶解後,於 此溶液中加入氧雜環丁烷(A) ( 0.1 5g ) 、NMP(5.51g) 、BCS ( 26.6g )後攪拌,得到液晶配向處理劑[15]。 使用所得到的液晶配向處理劑[15],除了液晶爲 MLC-660 8 ( Merk Japan公司製)以外,其餘與實施例 1 同樣地製作液晶盒,接著測量硏磨處理的壓入量0.3 m m之 液晶注入後的初期、及以1 2 0 °C加熱處理5小時後的傾斜 角,關於初期及各加熱處理後的液晶盒,用偏光顯微鏡觀 察確認液晶的配向均勻性的結果,任何液晶盒皆無配向不 良,液晶皆均勻地配向。 傾斜角的測量結果,列示於表1。 (實施例1 1 ) 於合成例7所得到的聚醯亞胺粉末(G ) ( 2.9 8 g )中 加入NMP ( 17.5g),以8〇°C攪拌40小時使其溶解後,於 此溶液中加入氧雜環丁烷(A) (0.30g) 、NMP(6.61g) 、BCS ( 27.3g)後攪拌,得到液晶配向處理劑[16]。 使用所得到的液晶配向處理劑[1 6],除了液晶爲 MLC-660 8 ( Merk Japan公司製)以外,其餘與實施例 1 同樣地製作液晶盒,接著測量硏磨處理的壓入量〇.3mm之 液晶注入後的初期、及以1 20 °C加熱處理5小時後的傾斜 角,關於初期及各加熱處理後的液晶盒,用偏光顯微鏡觀 -61 - 200841093 察確認液晶的配向均勻性的結果,任何液晶盒皆無配向不 良,液晶皆均勻地配向。 傾斜角的測量結果,列示於表1。 (實施例1 2 ) 於合成例7所得到的聚醯亞胺粉末(G) ( 3.01g)中 加入NMP ( 17.7g),以80°C攪拌40小時使其溶解後,於 此溶液中加入氧雜環丁烷(C ) ( 0.1 5g ) 、NMP ( 5.41 g ) 、BCS ( 26.3g)後攪拌,得到液晶配向處理劑[17]。 使用所得到的液晶配向處理劑[17],除了液晶爲 MLC-660 8 ( Merk Japan公司製)以外,其餘與實施例i 同樣地製作液晶盒,接著測量硏磨處理的壓入量0.3mm之 液晶注入後的初期、及以1 20°C加熱處理5小時後的傾斜 角,關於初期及各加熱處理後的液晶盒,用偏光顯微鏡觀 察確認液晶的配向均勻性的結果,任何液晶盒皆無配向不 良,液晶皆均勻地配向。 傾斜角的測量結果,列示於表1。 (比較例6) 於合成例5所得到的聚醯亞胺粉末(E) ( 2.91g)中 加入NMP ( 17.1g),以80 °C攪拌40小時使其溶解後,於 此溶液中加入NMP (4.18g) 、BCS(26.3g)後攪拌,得 到液晶配向處理劑[18]。 使用所得到的液晶配向處理劑[1 8 ],除了液晶爲 -62- 200841093 MLC-6608 ( Merk Japan公司製)以外,其餘與實施例 1 同樣地製作液晶盒,接著測量硏磨處理的壓入量〇.3mm之 液晶注入後的初期、及以120 °C加熱處理5小時後的傾斜 角,關於初期及各加熱處理後的液晶盒,用偏光顯微鏡觀 察確認液晶的配向均勻性的結果,任何液晶盒皆無配向不 良,液晶皆均勻地配向。 傾斜角的測量結果,列示於表1。 (比較例7 ) 於合成例6所得到的聚醯亞胺粉末(F ) ( 3.05g )中 加入NMP ( 17.9g ),以80 °C攪拌40小時使其溶解後,於 此溶液中加入NMP ( 4.46g ) 、BCS ( 25.4g )後攪拌,得 到液晶配向處理劑[19]。 使用所得到的液晶配向處理劑[19],除了液晶爲 MLC-6608 (Merk Japan公司製)以外,其餘與實施例 i 同樣地製作液晶盒,接著測量硏磨處理的壓入量0 · 3 mm之 液晶注入後的初期、及以120 °C加熱處理5小時後的傾斜 角’關於初期及各加熱處理後的液晶盒,用偏光顯微鏡觀 察確認液晶的配向均勻性的結果,任何液晶盒皆無配向不 良,液晶皆均勻地配向。 傾斜角的測量結果’列不於表1。 (比較例8) 於合成例7所得到的聚醯亞胺粉末(G ) ( 3.00g )中 -63- 200841093 加入NMP ( 17.7g),以80°C攪拌40小時使其溶解後,於 此溶液中加入NMP ( 4 · 3 5 g ) 、B C S ( 2 5 · 1 g )後攪拌,得 到液晶配向處理劑[20]。 使用所得到的液晶配向處理劑[20],除了液晶爲 MLC-6608 ( Merk Japan公司製)以外,其餘與實施例1 同樣地製作液晶盒,接著測量硏磨處理的壓入量0.3mm之 液晶注入後的初期、及以1 20°C加熱處理5小時後的傾斜 角,關於初期及各加熱處理後的液晶盒,用偏光顯微鏡觀 察確認液晶的配向均勻性的結果,任何液晶盒皆無配向不 良,液晶皆均勻地配向。 傾斜角的測量結果,列示於表1。 (比較例9) 於合成例6所得到的聚醯亞胺粉末(F ) ( 3 · 0 1 g )中Then, oxetane (B) (0.03 g), NMP (2.41 g), and BCS (2.10 g) were added, followed by stirring to obtain a liquid crystal alignment treatment agent [5]. Using the obtained liquid crystal alignment treatment agent [5], a liquid crystal cell was produced in the same manner as in Example 1, and the initial stage after liquid crystal injection in which the pressing amount of the honing treatment was 0·3 mm and the heat treatment at 1200 ° C were measured. For each of the tilt angles after the hour, the liquid crystal cell after the initial and each heat treatment was observed by a polarizing microscope to confirm the uniformity of alignment of the liquid crystal, and any liquid crystal cell was not misaligned, and the liquid crystals were uniformly aligned. The measurement results of the tilt angle are shown in Table 1. (Comparative Example 1) NMP (3.06 g) and BCS (2.12 g) were added to the polyamic acid solution (A) (6.9 g) obtained in Synthesis Example 1 and stirred to obtain a liquid crystal alignment treatment agent [ 6]. Using the obtained liquid crystal alignment treatment agent [6], a liquid crystal cell was produced in the same manner as in Example 1 -54-200841093, and the amount of press-in of the honing treatment was measured, and the initial stage after the liquid crystal injection of 3 mm and the temperature of 1 20 ° were measured. C. The respective inclination angles after the heat treatment for 5 hours, as a result of observing the alignment uniformity of the liquid crystal by the polarizing microscope with respect to the liquid crystal cell after the initial stage and each heat treatment, any liquid crystal cell was not misaligned, and the liquid crystals were uniformly aligned. The measurement results of the tilt angle are shown in Table 1. (Comparative Example 2) NMP (2.01 g) and BCS (1.99 g) were added to the polyamic acid solution (B) (6·01 g) obtained in Synthesis Example 2, followed by stirring to obtain a liquid crystal alignment treatment agent. [7]. Using the obtained liquid crystal alignment treatment agent [7], a liquid crystal cell was produced in the same manner as in Example 1, and the initial stage after liquid crystal injection of 0·3 mm of the honing treatment and the heat treatment at 120 ° C were measured. For each of the tilt angles after 5 hours, the liquid crystal cell after the initial and each heat treatment was observed by a polarizing microscope to confirm the uniformity of alignment of the liquid crystal, and any liquid crystal cell was not misaligned, and the liquid crystals were uniformly aligned. The measurement results of the tilt angle are shown in Table 1 ° (Comparative Example 3). In the polyamic acid solution (A) (6.0 〇g) obtained in Synthesis Example 1, epoxy (A) (O.Ug) was added. After stirring with NMP (4.75 g) and BCS (2.5 2 g), a liquid crystal alignment treatment agent [8] was obtained. Using the obtained liquid crystal alignment treatment agent [8], a liquid crystal cell was produced in the same manner as in Example 1 -55-200841093, and the amount of press-in of the honing treatment was measured, and the initial stage after the liquid crystal injection of 3 mm and the temperature of 1 20 ° were measured. In the initial state of the liquid crystal cell, the so-called flow alignment in which the liquid crystal is aligned toward the liquid crystal flow direction during liquid crystal injection is observed in the initial state of the liquid crystal cell, and the flow alignment is not eliminated in each stage after the heat treatment. Further, since the discrimination line occurs due to the heat treatment, the tilt angle of the liquid crystal cell cannot be measured because such a misalignment occurs. Further, in the measurement, in addition to the press-in amount of 0.1 mm, the initial angle after liquid crystal injection of the liquid crystal cell produced by the same method as described above and the tilt angle after heat treatment at 10 ° C for 5 hours were observed in the initial state. Flow alignment, this flow alignment is not eliminated after heat treatment, and the discrimination line occurs, so the tilt angle cannot be measured. The measurement results of the tilt angle are shown in Table 1. (Comparative Example 4) In the polyamic acid solution (A) (6.05 g) obtained in Synthesis Example 1, the force Q was incorporated into epoxy (A) (0.06 g), NMP (4.03 g), and BCS (2.34 g). After stirring, a liquid crystal alignment treatment agent [9] was obtained. Using the obtained liquid crystal alignment treatment agent [9], a liquid crystal cell was produced in the same manner as in Example 1, and the initial stage after the liquid crystal injection of the honing treatment and the heat treatment at 10 ° C for 5 hours were measured. As for the initial liquid crystal cell, the alignment uniformity of the liquid crystal was confirmed by a polarizing microscope. The alignment was poor and the liquid crystal was uniformly aligned. However, after the heat treatment was performed at 12 ° C for 5 hours, a discrimination line occurred. Unable to measure -56- 200841093 The tilt angle of the liquid crystal cell after heat treatment at 1 2 0 °C for 5 hours. Further, in the initial state, the measurement was carried out in the initial state, except that the press-in amount was set to 0.1 mm, and the inclination angles at the initial stage after liquid crystal injection of the liquid crystal cell produced by the same method as described above and after heat treatment at 10 ° C for 5 hours were obtained. Seeing the flow alignment 'this flow alignment is not eliminated after heat treatment, plus the discrimination line occurs, so the tilt angle cannot be measured. The measurement results of the tilt angle are shown in Table 1. (Comparative Example 5) In the polyamic acid solution (A) (6.00 g) obtained in Synthesis Example 1, epoxy (B) (0.06 g), NMP (4.0 2 g), and BCS (2 · 3) were introduced. After 5 g), the mixture was stirred to obtain a liquid crystal alignment treatment agent [1 〇]. Using the obtained liquid crystal alignment treatment agent [10], a liquid crystal cell was produced in the same manner as in Example 1, and the initial stage after liquid crystal injection in which the pressing amount of the honing treatment was 0.3 mm and the heat treatment at 120,000 °C were measured. As for the initial tilt angles, the liquid crystal cell was observed by a polarizing microscope, and the alignment uniformity of the liquid crystal was confirmed. The alignment was poor and the liquid crystal was uniformly aligned. However, after the heat treatment at 120 ° C for 5 hours, a discrimination line occurred. Therefore, the tilt angle of the liquid crystal cell after heat treatment at 1200 ° C for 5 hours could not be measured. Further, in the initial state, the measurement was carried out in the initial state, except that the press-in amount was set to 0.1 mm, and the inclination angles at the initial stage after liquid crystal injection of the liquid crystal cell produced by the same method as described above and after heat treatment at 10 ° C for 5 hours were obtained. When the flow alignment is seen, the flow alignment is not eliminated after the heat treatment, and, in addition, the discrimination line occurs, so the inclination angle cannot be measured. -57- 200841093 The measurement results of the tilt angle are shown in Table i. (Example 6) NMP (1·7·1 g) was added to the polyimine powder (e) (2·9 1 g) obtained in Synthesis Example 5, and the mixture was stirred at 80 ° C for 40 hours to be dissolved. In this solution, oxetane (A) (〇·60 g), Μ Μ P (1 2.2 g), and BCS (25·7 g) were added and stirred to obtain a liquid crystal alignment treatment agent [i丨]. φ Using the obtained liquid crystal alignment treatment agent [11], the liquid crystal cell was produced in the same manner as in Example j except that the liquid crystal was 'MLC-660 8 (manufactured by Merk Japan Co., Ltd.), and then the press-in amount of the honing treatment was measured. - The initial angle after liquid crystal injection of 3 mm and the tilt angle after heat treatment at 1200 °C for 5 hours. As a result of observing the uniformity of alignment of the liquid crystal with a polarizing microscope for the initial and each liquid crystal cell after heat treatment, The liquid crystal cells have no misalignment, and the liquid crystals are evenly aligned. Further, regarding the liquid crystal cell prepared by the same method as the above, except that the press-in amount of the honing treatment was set to 0.1 mm, the tilt angle after the liquid crystal injection was measured and the tilt angle after heat treatment at 10 ° C for 5 hours was measured. As a result of observing the alignment uniformity of the liquid crystal by a polarizing microscope, the liquid crystal cell was not misaligned in any of the liquid crystal cells, and the liquid crystals were evenly aligned. (Example 7) NMP (18.0 g) was added to the polyimine powder (E) (3.05 g) obtained in Synthesis Example 5, and the mixture was stirred at 80 ° C for 40 hours to dissolve, and then oxygen was added to the solution. Heterocyclic butane (A) (〇.31g), NMP (6.55 g) -58-200841093, and BCS (28.0 g) were stirred to obtain a liquid crystal alignment treatment agent [12]. The liquid crystal cell was produced in the same manner as in Example 1 except that the liquid crystal was MLC-660 8 (manufactured by Merk Japan Co., Ltd.), and the amount of press-in of the honing treatment was measured. In the initial stage after the liquid crystal injection of 3 mm and the inclination angle after heat treatment at 10 ° C for 5 hours, the liquid crystal cell after the initial and each heat treatment was observed by a polarizing microscope to confirm the uniformity of alignment of the liquid crystal, and any liquid crystal cell was observed. None of the alignment is poor, and the liquid crystals are evenly aligned. Further, regarding the liquid crystal cell produced by the same method as described above except that the press-in amount was set to 〇1 mm, the respective tilt angles after the liquid crystal injection was measured and the heat treatment at 10 ° C for 5 hours was measured. When the liquid crystal cell was observed by a polarizing microscope to confirm the uniformity of the alignment of the liquid crystal, any of the liquid crystal cells had no misalignment, and the liquid crystals were evenly aligned. The measurement results of the tilt angle are shown in Table 1. (Example 8) NMP (1. 6 g) was added to the polyimine powder (E) (3.0 g) obtained in Synthesis Example 5, and the mixture was stirred at 80 ° C for 40 hours to dissolve the solution. An oxetane (A) (0.15 g), NMP (5·5 1 g), and BCS (26. 3 g) were added thereto, followed by stirring to obtain a liquid crystal alignment treatment agent [13]. The obtained liquid crystal alignment treatment agent [13] was prepared in the same manner as in Example 1 except that the liquid crystal was MLC-660 8 (manufactured by Merk Japan Co., Ltd.), and then the amount of press-in of the honing treatment was measured. In the initial stage after the liquid crystal injection of mm and the inclination of -59 to 200841093 after heat treatment for 5 hours, the liquid crystal cell after the initial and each heat treatment was observed by a polarizing microscope to confirm the uniformity of alignment of the liquid crystal. As a result, any of the liquid crystal cells have no misalignment, and the liquid crystals are evenly aligned. Further, regarding the liquid crystal cell produced by the same method as described above except that the press-in amount was set to 0.1 mm, the tilt angles at the initial stage after liquid crystal injection and after heat treatment at 120 ° C for 5 hours were measured. As a result of observing the alignment uniformity of the liquid crystal by a polarizing microscope, any of the liquid crystal cells had no misalignment, and the liquid crystals were evenly aligned. The measurement results of the tilt angle are shown in Table 1. (Example 9) NMP (18.4 g) was added to the polyimine powder (F) (3.12 g) obtained in Synthesis Example 6, and the mixture was stirred at 80 ° C for 40 hours to dissolve, and then oxygen was added to the solution. Heterocyclic butane (A) (0.31 g), NMP (6.80 g), and BCS (28.6 g) were stirred to obtain a liquid crystal alignment treatment agent [14]. Using the obtained liquid crystal alignment treatment agent [14], a liquid crystal cell was produced in the same manner as in Example i except that the liquid crystal was MLC-660 8 (manufactured by Merk Japan Co., Ltd.), and then the indentation amount of the honing treatment was measured. In the initial stage after the injection of the liquid crystal of mm and the tilt angle after heat treatment at 1200 ° C for 5 hours, the liquid crystal cell after the initial and each heat treatment was observed by a polarizing microscope to confirm the uniformity of alignment of the liquid crystal, and any liquid crystal cell was observed. None of the mismatched 'liquid crystals are evenly aligned. The measurement results of the tilt angle are shown in Table 1. -60-200841093 (Example 1 〇) NMP (1.79 g) was added to the polyimine powder (F) (3.04 g) obtained in Synthesis Example 6, and the mixture was dissolved in 8 (TC for 40 hours). To the solution, oxetane (A) (0.15 g), NMP (5.51 g), and BCS (26.6 g) were added, followed by stirring to obtain a liquid crystal alignment treatment agent [15]. Using the obtained liquid crystal alignment treatment agent [15] In the same manner as in Example 1, except that the liquid crystal was MLC-660 8 (manufactured by Merk Japan Co., Ltd.), the liquid crystal cell was produced in the same manner as in Example 1, and the initial stage after the liquid crystal injection of 0.3 mm of the honing treatment was measured, and 1 2 was measured. The tilt angle after heat treatment at 0 °C for 5 hours, and the liquid crystal cell after the initial and each heat treatment were observed by a polarizing microscope to confirm the uniformity of alignment of the liquid crystal, and any liquid crystal cell was not misaligned, and the liquid crystals were uniformly aligned. The measurement results of the angles are shown in Table 1. (Example 1 1 ) NMP (17.5 g) was added to the polyimine powder (G) (2.98 g) obtained in Synthesis Example 7 at 8 ° C. After stirring for 40 hours to dissolve, oxetane (A) (0.30 g) and NMP (6.61 g) were added to the solution. After the BCS (27. 3g) was stirred, the liquid crystal alignment treatment agent [16] was obtained. The obtained liquid crystal alignment treatment agent [16] was used except that the liquid crystal was MLC-660 8 (manufactured by Merk Japan Co., Ltd.). In the same manner, a liquid crystal cell was produced, and then the initial amount after the liquid crystal injection of 3 mm was measured, and the tilt angle after heat treatment at 10 ° C for 5 hours was measured, and the liquid crystal cell after the initial and each heat treatment was measured. As a result of observing the alignment uniformity of the liquid crystal, the liquid crystal was uniformly aligned, and the liquid crystals were evenly aligned. The measurement results of the tilt angle are shown in Table 1. (Example 1 2 ) NMP (1.77 g) was added to the polyimine powder (G) (3.01 g) obtained in Synthesis Example 7, and after stirring at 80 ° C for 40 hours to dissolve, oxetane was added to the solution ( C) (0.15g), NMP (5.41g), and BCS (26.36g) were stirred to obtain a liquid crystal alignment treatment agent [17]. The obtained liquid crystal alignment treatment agent [17] was used except that the liquid crystal was MLC-660 8 ( Liquid crystal was produced in the same manner as in Example i except for Merk Japan Co., Ltd. Then, the initial stage after the liquid crystal injection of 0.3 mm of the honing treatment and the inclination angle after heat treatment at 1200 ° C for 5 hours were measured, and the liquid crystal cell after the initial and each heat treatment was observed by a polarizing microscope. As a result of the uniformity of alignment of the liquid crystal, any liquid crystal cell has no misalignment, and the liquid crystals are evenly aligned. The measurement results of the tilt angle are shown in Table 1. (Comparative Example 6) NMP (1.71 g) was added to the polyimine powder (E) (2.91 g) obtained in Synthesis Example 5, and the mixture was stirred at 80 ° C for 40 hours to dissolve, and then NMP was added to the solution. (4.18g) and BCS (26.3g) were stirred to obtain a liquid crystal alignment treatment agent [18]. Using the obtained liquid crystal alignment treatment agent [1 8 ], a liquid crystal cell was produced in the same manner as in Example 1 except that the liquid crystal was -62-200841093 MLC-6608 (manufactured by Merk Japan Co., Ltd.), and then the press-in of the honing treatment was measured. 〇 〇 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 The liquid crystal cells have no misalignment, and the liquid crystals are evenly aligned. The measurement results of the tilt angle are shown in Table 1. (Comparative Example 7) NMP (1.79 g) was added to the polyimine powder (F) (3.05 g) obtained in Synthesis Example 6, and after stirring at 80 ° C for 40 hours, NMP was added to the solution. (4.66 g) and BCS (25.4 g) were stirred, and a liquid crystal alignment treatment agent [19] was obtained. Using the obtained liquid crystal alignment treatment agent [19], a liquid crystal cell was produced in the same manner as in Example i except that the liquid crystal was MLC-6608 (manufactured by Merk Japan Co., Ltd.), and then the indentation amount of the honing treatment was measured to be 0 · 3 mm. The initial angle after the liquid crystal injection and the tilt angle after heat treatment at 120 ° C for 5 hours. As a result of observing the alignment uniformity of the liquid crystal by the polarizing microscope with respect to the liquid crystal cell after the initial and each heat treatment, any liquid crystal cell was not aligned. Poor, the liquid crystals are evenly aligned. The measurement results of the tilt angle are listed in Table 1. (Comparative Example 8) In the polyimine powder (G) (3.000 g) obtained in Synthesis Example 7, -63-200841093 was added to NMP (17. 7 g), and the mixture was stirred at 80 ° C for 40 hours to dissolve therein. NMP (4 · 3 5 g ) and BCS (25 · 1 g) were added to the solution, followed by stirring to obtain a liquid crystal alignment treatment agent [20]. Using the obtained liquid crystal alignment treatment agent [20], a liquid crystal cell was produced in the same manner as in Example 1 except that the liquid crystal was MLC-6608 (manufactured by Merk Japan Co., Ltd.), and then a liquid crystal having a press-in amount of 0.3 mm was measured. The initial angle after the injection and the tilt angle after heat treatment at 1200 ° C for 5 hours, and the liquid crystal cell after the initial and each heat treatment were observed by a polarizing microscope to confirm the uniformity of alignment of the liquid crystal, and any liquid crystal cell was not misaligned. The liquid crystals are evenly aligned. The measurement results of the tilt angle are shown in Table 1. (Comparative Example 9) In the polyimine powder (F) (3 · 0 1 g ) obtained in Synthesis Example 6

加入NMP ( 17.7g),以80°C攪拌40小時使其溶解後,於 此溶液中加入環氧(A ) ( 0.60g ) 、NMP ( 8.80g ) 、:BCS (3 O.Og)後攪拌,得到液晶配向處理劑[21]。 使用所得到的液晶配向處理劑[21 ],除了液晶爲 MLC-660 8 ( Merk Japan公司製)以外,其餘與實施例 1 同樣地製作液晶盒,接著測量硏磨處理的壓入量〇.3mm之 液晶注入後的初期、及以1 20 °C加熱處理5小時後的傾斜 角,關於此液晶盒的初期狀態,觀察到液晶注入時液晶朝 向液晶流動方向配向之所謂的流動配向,而且,熱處理後 的各階段中此流動配向亦未消除,再加上,因爲熱處理而 -64 - 200841093 發生discrimination line ’因爲發生如此的配向不良,故 無法測量此液晶盒的傾斜角。 而且,測量除了將壓入量定爲0.1mm,其餘與上述相 同作法所製作的液晶盒之液晶注入後的初期及以1 2(TC加 熱處理5小時後的傾斜角,於初期狀態,看到流動配向, 熱處理後此流動配向亦未消除,再加上,發生 discrimination line,因此無法測量此液晶盒的傾斜角。 傾斜角的測量結果,列示於表1。 (比較例1 〇 ) 於合成例6所得到的聚醯亞胺粉末(F ) ( 3 · 0 0 g )中 加入NMP ( 17.5g),以80°C攬拌40小時使其溶解後,於 此溶液中加入環氧(A) ( 0.30g ) ^ NMP ( 6.71 g ) 、:BCs (27.5g )後攪拌,得到液晶配向處理劑[22]。 使用所得到的液晶配向處理劑[22],除了液晶爲 MLC_660 8 ( Merk Japan公司製)以外,其餘與實施例 ! 同樣地製作液晶盒,接著測量硏磨處理的壓入量〇 . 3 mm之 液晶注入後的初期、及以1 20°C加熱處理5小時後的傾斜 角,關於初期及各熱處理後的液晶盒,藉由偏光顯微鏡觀 察確認液晶的配向均勻性的結果,任何液晶盒皆無配向不 良,液晶皆均勻地配向。 而且,測量除了將壓入量定爲0.1 mm,其餘與上述相 同作法所製作的液晶盒之液晶注入後的初期及以1 2 〇 °C加 熱處理5小時後的傾斜角的結果,於初期狀態,看到流動 -65- 200841093 配向,熱處理後此流動配向亦未消除,再加上,發生 discrimination line,因此無法測量傾斜角。 傾斜角的測量結果,列示於表1。 (比較例1 1 ) 於合成例6所得到的聚醯亞胺粉末(F) ( 3.〇3g)巾 加入NMP ( 17.8g),以80 °C攪拌40小時使其溶解後,於 此溶液中加入環氧(A) ( 0.15g ) 、NMP ( 5.60g) 、Bcs (26.3g )後攪拌,得到液晶配向處理劑[23]。 使用所得到的液晶配向處理劑[23],除了液晶爲 MLC-660 8 ( Merk Japan公司製)以外,其餘與實施例 1 同樣地製作液晶盒,接著測量硏磨處理的壓入量0.3mm之 液晶注入後的初期、及以1 20 °C加熱處理5小時後的傾斜 角,關於初期及各熱處理後的液晶盒,藉由偏光顯微鏡觀 察確認液晶的配向均勻性的結果,任何液晶盒皆無配向不 良,液晶皆均勻地配向。 而且,測量除了將壓入量定爲0.1mm,其餘與上述相 同作法所製作的液晶盒之液晶注入後的初期及以120 °C加 熱處理5小時後的傾斜角的結果,於初期狀態,看到流動 配向,熱處理後此流動配向亦未消除,再加上,發生 discrimination line,因此無法測量傾斜角。 傾斜角的測量結果,列示於表1。 (比較例1 2 ) -66 - 200841093After adding NMP ( 17.7 g) and stirring at 80 ° C for 40 hours, epoxy (A ) (0.60 g), NMP (8.80 g), and BCS (3 O.Og) were added to the solution and stirred. A liquid crystal alignment treatment agent [21] was obtained. The liquid crystal cell was produced in the same manner as in Example 1 except that the liquid crystal was MLC-660 8 (manufactured by Merk Japan Co., Ltd.), and the amount of press-in of the honing treatment was measured. In the initial stage after liquid crystal injection and the inclination angle after heat treatment at 10 ° C for 5 hours, in the initial state of the liquid crystal cell, the so-called flow alignment in which the liquid crystal is aligned in the liquid crystal flow direction during liquid crystal injection is observed, and heat treatment is performed. This flow alignment was not eliminated in the subsequent stages, and, because of the heat treatment, the discrimination line of -64 - 200841093 occurred because the tilt angle of the liquid crystal cell could not be measured because of such poor alignment. Further, in the measurement, in addition to the press-in amount of 0.1 mm, the initial stage after the liquid crystal injection of the liquid crystal cell produced by the same method as described above and the tilt angle after 12 hours of the TC heat treatment were observed in the initial state. Flow alignment, this flow alignment is not eliminated after heat treatment, and the discrimination line occurs, so the tilt angle of the liquid crystal cell cannot be measured. The measurement results of the tilt angle are shown in Table 1. (Comparative Example 1 〇) Synthesis NMP (17.5 g) was added to the polyimine powder (F) (3·0 0 g) obtained in Example 6, and after 80 ° C was mixed at 80 ° C to dissolve it, epoxy (A was added to the solution). (0.30g) ^ NMP ( 6.71 g ), :BCs (27.5g), and stirred to obtain a liquid crystal alignment treatment agent [22]. The obtained liquid crystal alignment treatment agent [22] is used, except that the liquid crystal is MLC_660 8 ( Merk Japan In the same manner as in the example, the liquid crystal cell was produced in the same manner as in the example. Next, the amount of press-in of the honing treatment was measured, and the initial angle after liquid crystal injection of 3 mm and the tilt angle after heat treatment at 10 ° C for 5 hours were measured. , for the initial and each heat-treated liquid crystal cell, by polarized light As a result of microscopic observation confirming the uniformity of alignment of the liquid crystal, any liquid crystal cell has no misalignment, and the liquid crystals are evenly aligned. Moreover, in addition to the measurement of the press-in amount to 0.1 mm, the liquid crystal of the liquid crystal cell produced by the same method as described above is measured. As a result of the initial angle after the injection and the inclination angle after heat treatment at 1 2 〇 ° C for 5 hours, the flow-65-200841093 alignment was observed in the initial state, and the flow alignment was not eliminated after the heat treatment, and the discrimination occurred. Line, therefore, the tilt angle cannot be measured. The measurement results of the tilt angle are shown in Table 1. (Comparative Example 1 1 ) The polyimine powder (F) ( 3.〇3g) obtained in Synthesis Example 6 was added to NMP. (17. 8g), after stirring at 80 ° C for 40 hours to dissolve, epoxy (A) (0.15g), NMP (5.60g), and Bcs (26.3g) were added to the solution, followed by stirring to obtain a liquid crystal alignment treatment. In the same manner as in Example 1, except that the liquid crystal was MLC-660 8 (manufactured by Merk Japan Co., Ltd.), the liquid crystal cell was produced, and then the pressure of the honing treatment was measured. After the injection of 0.3mm liquid crystal In the initial stage and the inclination angle after heat treatment at 1200 ° C for 5 hours, the liquid crystal cell after the initial and each heat treatment was observed by a polarizing microscope to confirm the uniformity of alignment of the liquid crystal, and any liquid crystal cell was not misaligned. Evenly, the measurement was performed, except that the amount of press-in was 0.1 mm, and the results of the initial stage after liquid crystal injection of the liquid crystal cell produced by the same method as described above and the inclination angle after heat treatment at 120 ° C for 5 hours were measured. In the initial state, the flow alignment was observed, and the flow alignment was not eliminated after the heat treatment. In addition, the discrimination line occurred, so the inclination angle could not be measured. The measurement results of the tilt angle are shown in Table 1. (Comparative Example 1 2 ) -66 - 200841093

於合成例6所得到的聚醯亞胺粉末(F) ( 2.93g)中 加入NMP ( 17.1g),以80 °C攪拌40小時使其溶解後,於 此溶液中加入環氧(B ) ( 0.30g ) 、NMP ( 5.50g ) 、BCS (2 5.7g )後攪拌,得到液晶配向處理劑[24]。 使用所得到的液晶配向處理劑[24],除了液晶爲 MLC-660 8 ( Merk Japan公司製)以外,其餘與實施例i 同樣地製作液晶盒,接著測量硏磨處理的壓入量〇. 3 mm之 液晶注入後的初期、及以120 °C加熱處理5小時後的傾斜 角’關於初期及各熱處理後的液晶盒,藉由偏光顯微鏡觀 察確認液晶的配向均勻性的結果,任何液晶盒皆無配向不 良’液晶皆均勻地配向。 而且,測量除了硏磨處理的壓入量定爲0.1mm,其餘 與上述相同作法所製作的液晶盒之液晶注入後的初期及以 1 20 °C加熱處理5小時後的傾斜角的結果,於初期狀態, 看到流動配向,熱處理後此流動配向亦未消除,再加上, 發生d i s c r i m i n a t i ο η 1 i n e,因此無法測量傾斜角。 傾斜角的測量結果,列示於表1。 -67- 200841093 表 1 (Α戚分 (B戚分 壓入量: 0.3mm 壓入量 0.1mm 初期 120〇C/5h 初期 120〇C/5h 實施例1 [1] 氧雜環丁烷(A) 5.0 4.9 5.2 5.1 實施例2 [2] 氧雜環丁烷(A) 5.7 5.6 5.8 5.8 實施例3 [3] 氧雜環丁烷(B) 5.3 5.3 5.5 5.5 實施例4 [41 氧雜環丁烷(A) 5.3 5.3 實施例5 [5] 氧雜環丁烷(B) 6.2 6.1 _ 比較例1 [6] Μ j\\\ 6.9 5.8 - - 比較例2 [7] Μ 7.8 7.0 - - 比較例3 [8] 環氧(A) *1 *2 *1 *2 比較例4 [9] 環氧(A) 5.5 *3 *1 *2 比較例5 [10] 環氧(B) 5.6 *3 *1 *2 實施例6 [11] 氧雜環丁烷(A) 84.8 85.4 85.1 85.2 實施例7 [12] 氧雜環丁烷(A) 85.2 85.6 85.6 85.6 實施例8 [13] 氧雜環丁烷(A) 86.2 86.7 86.5 86.5 實施例9 [14] 氧雜環丁烷(A) 87.9 88.3 - - 實施例10 [15] 氧雜環丁院(B) 88.4 88.6 - - 實施例11 [16] 氧雜環丁烷(A) 88.1 88.3 - - 實施例12 [17] 氧雜環丁烷(C) 88.5 88.6 • 比較例ό [18] Μ 86.0 88.3 - - 比較例7 [19] Μ y\\\ 87.4 89.0 - 比較例8 [20] 無 88.1 89.8 - - 比較例9 Ρ1] 環氧(A) *1 *2 *1 *2 比較例10 [22] 環氧(A) 89.6 89.7 *1 *2 比較例Π [23] 環氧(A) 89.2 89.8 *1 *2 比較例Π [241 環氧(B) 89.1 89.9 *1 *2 _ : 未評估 * 1 :藉由偏光顯微鏡觀察,於液晶盒內看到流動配 向。 * 2 :藉由偏光顯微鏡觀察,於液晶盒內看到流動配 向及 discrimination line。 . :藉由偏光顯微鏡觀察,於液晶盒內看到 discrimination line 〇 (各傾斜角,係液測量晶盒的中心及上下1 c m的3處 之平均値) -68- 200841093 由上述的結果,由 晶配向膜,與含有特定 有交聯性化合物之比較 晶的配向性無變化,而 的變化,傾斜角的安定 3〜5、及比較例9〜12, 明之特定交聯性化合物 的比較例,硏磨處理的 產業上的可利用性 藉由使用本發明的 斜角的安定性優異的液 膜之液晶顯示元件,因 TN元件、STN元件、 ^ 直配向型的液晶顯示元 再者,本發明中引 利申請案2006-297244 要的全部內容,作爲說 本發明的液晶配向處理劑得到的液 交聯性化合物之實施例1〜2與不含 例1〜2、及比較例6〜8比較下,液 且高溫處理後的傾斜角有低於1度 性提高許多。另一方面,如比較例 使用環氧系交聯性化合物取代本發 時,觀察到配向不良,特別是此等 壓入量低時,發生配向不良。 液晶配向處理劑,可得到液晶的傾 晶配向膜,此外,具有此液晶配向 爲其爲信賴性優異者,故適合用於 TFT液晶元件,而且更適合用於垂 件等。 用2006年11月1日申請的日本專 號的說明書、申請專利範圍、及摘 明書的揭示內容援用於本發明。 -69-NMP (1.71 g) was added to the polyimine powder (F) (2.93 g) obtained in Synthesis Example 6, and after stirring at 80 ° C for 40 hours to dissolve, epoxy (B) was added to the solution. 0.30 g), NMP (5.50 g), and BCS (2 5.7 g) were stirred, and a liquid crystal alignment treatment agent [24] was obtained. The liquid crystal cell was produced in the same manner as in Example i except that the liquid crystal was MLC-660 8 (manufactured by Merk Japan Co., Ltd.), and the amount of press-in of the honing treatment was measured. In the initial stage after the injection of the liquid crystal of mm and the inclination angle after heat treatment at 120 ° C for 5 hours. As for the liquid crystal cell after the initial and each heat treatment, the alignment uniformity of the liquid crystal was confirmed by a polarizing microscope. Poor alignment 'liquid crystals are evenly aligned. Further, as a result of measuring the amount of pressing of the honing treatment to be 0.1 mm, the results of the initial stage after liquid crystal injection of the liquid crystal cell produced by the same method as described above and the inclination angle after heat treatment at 10 ° C for 5 hours were In the initial state, the flow alignment was observed, and the flow alignment was not eliminated after the heat treatment. Further, discriminati ο η 1 ine occurred, so the inclination angle could not be measured. The measurement results of the tilt angle are shown in Table 1. -67- 200841093 Table 1 (Α戚分(B戚分压: 0.3mm Indentation 0.1mm Initial 120〇C/5h Initial 120〇C/5h Example 1 [1] Oxetane (A 5.0 4.9 5.2 5.1 Example 2 [2] Oxetane (A) 5.7 5.6 5.8 5.8 Example 3 [3] Oxetane (B) 5.3 5.3 5.5 5.5 Example 4 [41 Oxetane Alkane (A) 5.3 5.3 Example 5 [5] Oxetane (B) 6.2 6.1 _ Comparative Example 1 [6] Μ j\\\ 6.9 5.8 - - Comparative Example 2 [7] Μ 7.8 7.0 - - Comparison Example 3 [8] Epoxy (A) *1 *2 *1 *2 Comparative Example 4 [9] Epoxy (A) 5.5 *3 *1 *2 Comparative Example 5 [10] Epoxy (B) 5.6 *3 *1 *2 Example 6 [11] Oxetane (A) 84.8 85.4 85.1 85.2 Example 7 [12] Oxetane (A) 85.2 85.6 85.6 85.6 Example 8 [13] Oxetane Alkane (A) 86.2 86.7 86.5 86.5 Example 9 [14] Oxetane (A) 87.9 88.3 - - Example 10 [15] Oxetane (B) 88.4 88.6 - - Example 11 [16] Oxetane (A) 88.1 88.3 - - Example 12 [17] Oxetane (C) 88.5 88.6 • Comparative Example [18] Μ 86.0 88.3 - - Comparative Example 7 [19] Μ y\\ \ 87.4 89.0 - Comparative example 8 [20] No 88.1 89.8 - - Comparative Example 9 Ρ1] Epoxy (A) *1 *2 *1 *2 Comparative Example 10 [22] Epoxy (A) 89.6 89.7 *1 *2 Comparative Example Π [23] Epoxy (A) 89.2 89.8 *1 *2 Comparative Example 241 [241 Epoxy (B) 89.1 89.9 *1 *2 _ : Not evaluated * 1 : Flow alignment was observed in the liquid crystal cell by observation with a polarizing microscope. 2: The liquid alignment and the discrimination line were observed in the liquid crystal cell by observation under a polarizing microscope. : The discrimination line 看到 was observed in the liquid crystal cell by a polarizing microscope (the tilt angle was measured, and the center of the liquid crystal cell was measured and The average 値 of 3 points above and below 1 cm) -68- 200841093 From the above results, there is no change in the orientation of the crystal from the crystal to the film, and the change in the orientation of the crystal with respect to the specific crosslinkable compound ~5, and Comparative Examples 9 to 12, a comparative example of a specific crosslinkable compound, and an industrial useability of the honing treatment, by using a liquid crystal display element of a liquid film excellent in the stability of the oblique angle of the present invention, In the present invention, the TN element, the STN element, and the direct alignment type liquid crystal display element In the entire contents of the application 2006-297244, the liquid crosslinkable compounds obtained by the liquid crystal alignment treatment agent of the present invention are compared with the first to second examples, and the liquids are not contained in the examples 1 to 2 and the comparative examples 6 to 8. Moreover, the inclination angle after the high temperature treatment has a degree of improvement of less than 1 degree. On the other hand, when the epoxy-based crosslinkable compound was used in place of the present invention, a poor alignment was observed, and particularly when such a press-in amount was low, misorientation occurred. The liquid crystal alignment agent can obtain a tilting alignment film of a liquid crystal. Further, since this liquid crystal alignment is excellent in reliability, it is suitable for use in a TFT liquid crystal element, and is more suitable for use in a pendant or the like. The disclosure of the specification, the scope of the patent application, and the disclosure of the Japanese Patent Application, filed on Nov. 1, 2006, is hereby incorporated by reference. -69-

Claims (1)

200841093 十、申請專利範圍 1 · 一種液晶配向處理劑,其特徵係含有下述(A )成 份及(B )成份, (A) 成份:由聚醯胺酸及聚醯亞胺所成的群中所選 出的至少一種的聚合物、 (B) 成份:分子內中具有至少2個下述式[1]所表示 的氧雜環丁烷基之交聯性化合物, [化1]200841093 X. Patent application scope 1 · A liquid crystal alignment treatment agent characterized by containing the following (A) component and (B) component, (A) component: a group of polyglycine and polyimine At least one selected polymer, (B) component: a crosslinkable compound having at least two oxetanyl groups represented by the following formula [1] in the molecule, [Chemical Formula 1] 2 ·如申請專利範圍第1項之液晶配向處理劑,其中 (B )成份爲下述式[2]所表示的化合物, [化2]2. The liquid crystal alignment treatment agent according to item 1 of the patent application, wherein the component (B) is a compound represented by the following formula [2], [Chemical 2] [2] (式[2]中,Xi 表示 N、NH、CO、0、S、S02、Si、倍半 矽氧烷、聚矽氧烷、或碳數1〜20的有機基,此有機基中 亦可含有雜原子(N、Ο、S、Si) ; X2及X3各自獨立地 表示單鍵、:^11、(:〇、〇、8、8〇2、或碳數1〜20的有機基 ,此有機基中亦可含有雜原子(N、0、S、Si) ;Y!及Y2 各自獨立地表示碳數1〜20的有機基,此有機基中亦可含 -70- 200841093 有雜原子(N、0、S、Si) ;m、η各自獨立地表示〇〜20 的整數,且m + n表示2〜2 0的整數)。 3 .如申請專利範圍第1項之液晶配向處理劑’其中 (B )成份爲下述式[3]所表示的化合物,[2] (In the formula [2], Xi represents N, NH, CO, 0, S, S02, Si, sesquioxane, polyoxyalkylene, or an organic group having 1 to 20 carbon atoms, and this organic group It may also contain a hetero atom (N, Ο, S, Si); X2 and X3 each independently represent a single bond, :^11, (: 〇, 〇, 8, 8 〇 2, or an organic number of 1 to 20) The organic group may also contain a hetero atom (N, 0, S, Si); Y! and Y2 each independently represent an organic group having 1 to 20 carbon atoms, and the organic group may also contain -70-200841093 a hetero atom (N, 0, S, Si); m and η each independently represent an integer of 〇~20, and m + n represents an integer of 2 to 2 0. 3. Liquid crystal alignment as in claim 1 The treatment agent 'wherein the component (B) is a compound represented by the following formula [3], (式[3]中,X2及X3各自獨立地表示單鍵、NH、CO、◦、 S、S02、或碳數1〜20的有機基,此有機基中亦可含有雜 原子(N、0、S、Si) ; Y!及Υ2各自獨立地表示碳數 1〜2 0的有機基,此有機基中亦可含有雜原子(Ν、0、S、 Si) ;Zi 表示單鍵、NH、N(CH3) 、NHCO、CONH、 NHCONH、CO、COO、Ο、S、S〇2、CF2、C ( CF3) 2、Si(In the formula [3], X2 and X3 each independently represent a single bond, NH, CO, hydrazine, S, S02, or an organic group having 1 to 20 carbon atoms, and the organic group may further contain a hetero atom (N, 0). , S, Si); Y! and Υ2 each independently represent an organic group having a carbon number of 1 to 20, and the organic group may also contain a hetero atom (Ν, 0, S, Si); Zi represents a single bond, NH, N(CH3), NHCO, CONH, NHCONH, CO, COO, Ο, S, S〇2, CF2, C (CF3) 2, Si (CH3 ) 2、OSi ( CH3 ) 2、Si ( CH3 ) 2〇、〇Si ( CH3 ) 2〇 、或碳數1〜10的烷基;m、n各自獨立地表示〇〜l〇的整 數,且m + n表不2〜10的整數)。 4.如申請專利範圍第1項之液晶配向處理劑,其中 (B)成份爲下述式[4]所表示的化合物, [化4] [4] (式[4]中,Χι 表示 NH、N (CH3) 、NHCO、CON Η、 -71 - 200841093 NHCONH、CO、COO、OCO、〇、S、S02、CF2、C(CF3)2 、Si ( ch3 ) 2、OSi ( ch3) 2、Si ( ch3) 2o、或 OSi ( CH3) 20; Y2各自獨立地表示碳數1〜10的烷基)。 5 ·如申請專利範圍第1項之液晶配向處理劑,其中 (B)成份爲下述式[5]所表示的化合物, [化5](CH3) 2, OSi (CH3) 2, Si (CH3) 2〇, 〇Si(CH3) 2〇, or an alkyl group having 1 to 10 carbon atoms; m and n each independently represent an integer of 〇~l〇, And the m + n table is not an integer of 2 to 10). 4. The liquid crystal alignment treatment agent according to claim 1, wherein the component (B) is a compound represented by the following formula [4], [4] [in the formula [4], Χι means NH, N (CH3), NHCO, CON Η, -71 - 200841093 NHCONH, CO, COO, OCO, 〇, S, S02, CF2, C(CF3)2, Si (ch3) 2, OSi (ch3) 2, Si ( Ch3) 2o, or OSi(CH3)20; Y2 each independently represents an alkyl group having 1 to 10 carbon atoms). 5. The liquid crystal alignment treatment agent according to item 1 of the patent application, wherein the component (B) is a compound represented by the following formula [5], [Chem. 5] [5] (式[5]中,Xi爲N、碳數1〜20的脂肪族環、碳數1〜20 , 的芳香族環或碳數1〜20的伸烷基;Yi及Y2各自獨立地表 示碳數1〜10的烷基;m、η各自獨立地表示〇〜2 0的整數 ,且m + n表示2〜20的整數)。 6. 如申請專利範圍第1至5項中任一項之液晶配向 處理劑,其中相對於該(A )成份1 00質量份,(B )成份 # 含量爲0.1〜150質量份。 7. 如申請專利範圍第1至6項中任一項之液晶配向 處理劑,其係再含有有機溶劑。 8. 如申請專利範圍第7項之液晶配向處理劑,其中 該有機溶劑係在總有機溶劑中含有5〜80質量%之具有低表 面張力的溶劑。 9. 一種液晶配向膜,其特徵係由申請專利範圍第1 至8項中任一項所記載之液晶配向處理劑所得到。 10. —種液晶顯示元件,其特徵係具有申請專利範圍 -72- 200841093 第9項之液晶配向膜。 % m 鬱 蠓 -73- 200841093 七 指定代表圖: (一) 、本案指定代表圖為:無 (二) 、本代表圖之元件代表符號簡單說明··無[5] (In the formula [5], Xi is N, an aliphatic ring having 1 to 20 carbon atoms, an aromatic ring having 1 to 20 carbon atoms, or an alkylene group having 1 to 20 carbon atoms; and Yi and Y2 are each independently The ground represents an alkyl group having 1 to 10 carbon atoms; m and η each independently represent an integer of 〇~2 0 and m + n represents an integer of 2 to 20). 6. The liquid crystal alignment treatment agent according to any one of claims 1 to 5, wherein the (B) component # content is 0.1 to 150 parts by mass based on 100 parts by mass of the component (A). 7. The liquid crystal alignment treatment agent according to any one of claims 1 to 6, which further contains an organic solvent. 8. The liquid crystal alignment treatment agent according to claim 7, wherein the organic solvent contains 5 to 80% by mass of a solvent having a low surface tension in the total organic solvent. A liquid crystal alignment film obtained by the liquid crystal alignment treatment agent according to any one of claims 1 to 8. 10. A liquid crystal display element characterized by having a liquid crystal alignment film of the ninth application of the patent scope -72-200841093. % m 郁 蠓 -73- 200841093 VII Designated representative map: (1) The designated representative figure of this case is: None (2), the representative symbol of the representative figure is a simple description ·· 八、本案若有化學式時,請揭示最能顯示發明特徵的化學 式:8. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention:
TW096141006A 2006-11-01 2007-10-31 A liquid crystal alignment agent and a liquid crystal display device using the liquid crystal display device TWI407214B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006297244 2006-11-01

Publications (2)

Publication Number Publication Date
TW200841093A true TW200841093A (en) 2008-10-16
TWI407214B TWI407214B (en) 2013-09-01

Family

ID=39344190

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096141006A TWI407214B (en) 2006-11-01 2007-10-31 A liquid crystal alignment agent and a liquid crystal display device using the liquid crystal display device

Country Status (5)

Country Link
JP (1) JP5218062B2 (en)
KR (1) KR101455418B1 (en)
CN (1) CN101600989B (en)
TW (1) TWI407214B (en)
WO (1) WO2008053848A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI494374B (en) * 2009-12-25 2015-08-01 Nissan Chemical Ind Ltd A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device using the same

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5321781B2 (en) * 2007-01-09 2013-10-23 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
JP5532195B2 (en) * 2008-06-10 2014-06-25 Jsr株式会社 Liquid crystal aligning agent and liquid crystal display element
CN104136978A (en) * 2011-12-28 2014-11-05 日产化学工业株式会社 Liquid crystal aligning agent, liquid crystal display element, method for manufacturing liquid crystal display element, and polymerizable compound
CN107003566B (en) * 2014-11-13 2020-12-04 日产化学工业株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
KR102298368B1 (en) * 2015-02-09 2021-09-06 삼성디스플레이 주식회사 Photo alignment agent, photo alignment layer, liquid crystal display device and method of manufacturing the same
CN108034434A (en) * 2017-12-19 2018-05-15 深圳市华星光电技术有限公司 The production method of thermal polymerization auto-orientation liquid crystal material and liquid crystal display panel
TWI679217B (en) * 2018-03-02 2019-12-11 達興材料股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display device

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6665033B2 (en) * 2000-11-30 2003-12-16 International Business Machines Corporation Method for forming alignment layer by ion beam surface modification
CN100350471C (en) * 2001-07-26 2007-11-21 索尼株式会社 Optical recording/reproducing apparatus, focusing method therefor, and optical disk recording medium
WO2005040274A1 (en) * 2003-10-23 2005-05-06 Nissan Chemical Industries, Ltd. Aligning agent for liquid crystal and liquid-crystal display element
EP1775316A4 (en) * 2004-07-16 2011-11-02 Asahi Kasei Emd Corp Polyamide
JP4721747B2 (en) * 2004-09-30 2011-07-13 富士フイルム株式会社 Polymer film, liquid crystal alignment film, retardation plate, and liquid crystal display device
JP2007086399A (en) * 2005-09-22 2007-04-05 Dainippon Printing Co Ltd Optical element
JP4992436B2 (en) * 2006-03-24 2012-08-08 Jnc株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP5045241B2 (en) * 2006-07-10 2012-10-10 Jnc株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP4941120B2 (en) * 2006-09-01 2012-05-30 Jnc株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI494374B (en) * 2009-12-25 2015-08-01 Nissan Chemical Ind Ltd A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device using the same

Also Published As

Publication number Publication date
TWI407214B (en) 2013-09-01
KR20090076944A (en) 2009-07-13
CN101600989B (en) 2012-01-25
CN101600989A (en) 2009-12-09
JP5218062B2 (en) 2013-06-26
JPWO2008053848A1 (en) 2010-02-25
KR101455418B1 (en) 2014-10-27
WO2008053848A1 (en) 2008-05-08

Similar Documents

Publication Publication Date Title
TWI438226B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI447146B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW201410740A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW200841093A (en) Agent for alignment treatment of liquid crystal and liquid crystal display element using the same
TW201215631A (en) Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element equipped with the liquid crystal alignment film
TWI591098B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW200944553A (en) Liquid-crystal alignment material and liquid-crystal display element
KR20100103606A (en) Diamine compound, liquid crystal aligning agent, and liquid crystal display device using the same
TW201006869A (en) Liquid crystal alignment agent and liquid crystal display element
TWI520984B (en) Liquid crystal alignment film and a liquid crystal display element to the processing agent, with the liquid crystal
CN104837928A (en) Composition, liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element
TW201030056A (en) Liquid crystal aligning agent and liquid crystal display element using same
TWI499588B (en) Liquid crystal alignment film and a liquid crystal display element to the processing agent, with the liquid crystal
TWI452104B (en) A liquid crystal alignment agent and a liquid crystal display device using the liquid crystal display device
JP2016026162A (en) Diamine compound, polyimide precursor and polyimide
JP6183616B2 (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
TW201502202A (en) Liquid crystal orientation agent, liquid crystal orientation membrane, and liquid crystal display element using same
TW200846787A (en) Liquid crystal aligning agent, liquid crystal alignment layer and liquid crystal display element
JP5614412B2 (en) Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using the same
TWI525129B (en) A liquid crystal alignment agent, a liquid crystal alignment film, and a liquid crystal display device
TW200936647A (en) Vertical alignment type liquid crystal aligning agent and vertical alignment type liquid crystal display element
TW202130704A (en) Liquid crystal aligning agent, radical generation film and method for producing in-plane switching liquid crystal cell
TW201807020A (en) Liquid crystal alignment agent and use thereof